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CHAPTER I 
 
HEXOKINASE BINDING TO THE MITOCHONDRIA: CONVERGENCE OF 
METABOLIC AND APOPTOTIC PATHWAYS 
 
Research Motivation 
Recombinant therapeutic proteins, including monoclonal antibodies, are 
manufactured from the large-scale culture of mammalian cell lines. The ability of 
mammalian cell lines to perform proper protein assembly, protein folding, and the 
intricate post-translational modifications required for protein efficacy makes them the 
most desirable system to utilize in this process, as opposed to plant or microbial cell 
lines. Despite the intrinsic ability of mammalian cells to produce therapeutic proteins, 
limitations to efficient small and large-scale production do exist. Mammalian cells in 
culture are typically plagued by slow growth rates, low productivity, inefficient 
metabolism (i.e., high production of toxic metabolic by-products), nutrient depletion, and 
cell death (apoptosis). Understanding the intracellular mechanisms that contribute to cell 
growth and cell death is essential in improving the cellular “factories” that will produce 
the maximum amount of product.1, 2 
Surprisingly little is known about what instigates apoptotic cell death in 
bioprocesses or how it relates to other intracellular biochemical processes, such as protein 
signaling pathways or metabolism. Bioreactor stresses, such as decreased pH and nutrient 
depletion, are known to contribute to apoptotic cell death, but there is no clear 
explanation as to why cells in culture exhibit slowed growth and apoptotic cell death. 
Determining the cause(s) of cell death and consequently low productivity in industrial 
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cell culture and developing environmental and/or genetic strategies to circumvent such 
occurrences represents a great challenge to biotechnologists. Most research in the area of 
apoptotic cell death has focused on supplementation of apoptotic protein blocking agents 
into the culture media, up-regulation of protective proteins, such as Bcl-2, or fed-batch 
methodologies.3 These strategies have been somewhat successful in extending culture 
viabilities and delaying cell death, but only offer a partial solution to the problem of 
apoptosis or identify a specific cause.  
Since biopharmaceutical-producing cells manufacture their antibody products 
from major carbon sources in their environment (mainly glucose and glutamine) and the 
utilization of these sources determines cell growth and productivity, cellular metabolism 
is an attractive target of study for bioprocess optimization. Indeed, mammalian cells in 
batch cultures are known to exhibit decreasing metabolism, and there are no real 
explanations for this phenomenon.4-7 The connections between glycolytic metabolism and 
apoptosis through the interactions between hexokinase, a glycolytic enzyme, and the 
mitochondria are compelling to say the least, which clearly leads to speculation that 
higher rates of glucose consumption may play a role as a strong survival signal for the 
cell and/or potentially protect the cell against mitochondrial-mediated apoptosis. A 
portion of the total hexokinase molecules binds to the mitochondria where in cell-free 
studies it has been shown that conditions are more favorable for glycolysis, and this 
binding may protect the cell from apoptosis by impeding the release of apoptotic proteins 
into the cytosol.8, 9 If what the literature claims regarding hexokinase’s role in 
metabolism and apoptosis holds true in a biopharmaceutical-producing cell line, then 
future efforts to mitigate decreasing glycolysis and cell death would be complemented by 
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efforts to prevent hexokinase dissociation. This traverse between metabolism and 
apoptosis serves as the basis for this research project and the investigation of strategies to 
promote increased metabolism and cell survival in bioprocesses. As a whole, the aims of 
this research are to quantify the effects of induced hexokinase redistribution between the 
mitochondrial and cytosolic fractions on cell death and glycolysis and probe a possible 
occurrence of hexokinase redistribution in batch cultures, which may offer an explanation 
to the phenomenon of decreasing glucose consumption. Hexokinase dissociation from the 
mitochondria may also prove to be a very early marker of an active apoptotic mechanism 
in batch cultures. The study of this enzyme in particular is more desirable than studying 
the other key regulatory enzymes in glycolysis because hexokinase is the only known 
glycolytic enzyme to possess mitochondrial binding characteristics.10 
      
Specific Research Aims 
This research precisely investigates the dynamics of hexokinase localization 
between the mitochondria and cytosol in batch hybridoma cultures. Preliminarily, I 
performed an extensive study on the physiology of the high-viability batch cultures in T-
flasks and spinner flasks, and these data are presented in Chapter II. The subsequent 
studies are divided into three major aims: 
(I) Determine the effects of clotrimazole, a compound known to detach 
hexokinase from the mitochondria, on glucose consumption and apoptotic cell 
death of hybridoma cultures. 
(II) Verify the mitochondrial hexokinase dissociation effects of clotrimazole.  
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(III) Determine if the amount of hexokinase bound to mitochondria decreases over 
time in un-induced high-viability batch hybridoma cultures. 
       
Dissertation Organization 
 This dissertation is organized into 5 different chapters. Chapter I contains the 
specific research aims and a summary of the relevant literature supporting the project 
ideas. Chapter II contains results from the preliminary studies of high-viability batch 
hybridoma culture physiology. Results and discussion for specific aims I and II are 
presented in Chapter III, and Chapter IV contains the results of the batch measurements 
of mitochondrial hexokinase activity (aim III). The data collected during various 
experiments are analyzed to observe any suggested correlations among hexokinase 
disassociation from the mitochondria, inhibition of glycolysis, and occurrence of 
apoptotic cell death. The regulatory properties of mitochondrial hexokinase binding in 
terms of controlling glucose consumption (by efficiently phosphorylating glucose) and 
inhibiting the release of apoptotic proteins from the mitochondria are discussed. The last 
chapter, V, is devoted to summarizing and discussing the major findings of this study and 
their implications for apoptotic and metabolic control strategies in bioprocesses.  
 
Mitochondrial Hexokinase Links Metabolism and Apoptosis 
 
Literature Evidence for Mitochondrial Hexokinase Association 
 Hexokinase (HK) is an enzyme that catalyzes the first step of glycolysis, and it 
exists in 4 different isoforms, designated I, II, III, and IV. HKIV is known to exist only in 
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liver cells, and HKIII is known to only be present in small quantities of varying cell types 
and lacks the N-terminal amino acid sequence necessary for regulatory binding. HKI and 
HKII are known to associate with the mitochondria in a variety of different cell types, 
particularly cancer cells.11-13 Studies showing evidence of mitochondrial hexokinase 
association can be divided into 2 separate parts: (1) studies showing that hexokinase 
associates with the mitochondria and (2) studies showing that hexokinase binds to the 
voltage-dependent anion channel (VDAC) specifically. The vast majority of studies 
relating hexokinase and the mitochondria have been performed in a cell-free platform 
with isolated mitochondria, not whole-cell in vitro studies.   
Papers showing evidence of the presence of hexokinase in the particulate fractions 
of cells can be found as early at 1966. The first paper showing evidence of mitochondrial 
hexokinase binding was published in Biochemistry in 1969 by Craven and colleagues.14 
They used a fluorescent antibody labeling technique against hexokinase and observed the 
distribution of intracellular hexokinase in bovine brain tissues using microscopy. It was 
found that the majority of the fluorescent marker was centralized to the mitochondria. 
Since this publication, there have been various studies claiming an association of 
hexokinase with the mitochondria through a variety of techniques, such as confocal 
microscopy of rat brain astrocytes,15 measurement of hexokinase activity in isolated 
mitochondria of HeLa tumor, kidney, and brain cell types,16-19 and inhibitory studies 
using hexokinase monoclonal antibodies in human brain tissues.20  
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Hexokinase Binding to the VDAC 
 An outer-membrane binding site for hexokinase on the VDAC of the 
mitochondria is well established. A specific protein involved in mitochondrial hexokinase 
binding (and termed hexokinase binding protein (HBP)) was first uncovered in 1979 by 
co-sedimentation of the protein with hexokinase from mitochondrial lysates followed by 
SDS-PAGE.21 A few years later, the HBP was shown to have identically homology to the 
VDAC through SDS-PAGE, amino acid analysis, and the ability of the HBP to form 
pores.22, 23 This protein was not identified in a transformed cell line to be the VDAC itself 
until years later in 1986, when Nakashima and colleagues inhibited a binding site on the 
VDAC of isolated rat hepatoma mitochondria and showed that supplemented hexokinase 
would not bind when the site was occupied.24 Since these initial studies, there have been 
various review papers claiming hexokinase binding to the VDAC.11, 13, 25, 26 A very recent 
study showed specificity of hexokinase I binding to the VDAC of isolated rat liver 
mitochondria through peptide binding competition studies to a specific domain of the 
VDAC protein.27 Furthermore, hexokinase I has been shown to bind to purified VDAC 
protein by treatment with hexokinase followed by SDS-PAGE, and the treatment of 
purified VDAC reconstituted in a lipid bilayer with hexokinase induces VDAC channel 
closure through voltage measurements.28 Thus, there is a clearly solid body of supporting 
literature for interactions between hexokinase and the mitochondrial VDAC protein.       
 
Mitochondrial Hexokinase: Controller of Glycolysis and Apoptosis? 
The mitochondria are central to both energy metabolism and apoptotic cell death, 
and the fact that hexokinase possesses known molecular interactions with a key apoptotic 
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protein on the mitochondria is indeed compelling. Cellular energy in the form of ATP is 
produced at the mitochondria, and proteins that participate in apoptosis are housed there 
as well. In mitochondrial-mediated apoptosis, pro-apoptotic proteins are released from 
the inner membrane space into the cytosol through a mitochondrial trans-membrane 
protein called the voltage-dependent anion channel (VDAC) upon reception of apoptotic-
inducing stimuli. 29, 30 The opening of this protein is preceded by the opening of a protein 
on the inner mitochondrial membrane, termed the permeability transition pore (PTP). 
One of the most notable proteins released from the mitochondria during apoptosis is 
cytochrome c, and upon release, cytochrome-c binds with the Apaf-1 protein. In the 
presence of ATP or dATP, the cytochrome-c-Apaf-1 complex binds and activates 
procaspase-9, which in turn activates downstream caspases involved in the apoptotic 
pathway. 13, 31  
Cancer cells are known to exhibit an abnormal (higher) pattern of energy 
metabolism, potentially in part because more hexokinase is associated with the 
mitochondria in tumor cells as opposed to normal cells.10 The increased efficiency of 
mitochondrial hexokinase as opposed to cytosolic hexokinase has been hypothesized and 
studied in various ways. Cell-free studies with isolated hepatocyte, hybridoma, rat liver, 
and rat brain mitochondria have shown that the Km value for mitochondrial hexokinase is 
lower than that of cytosolic hexokinase, suggesting that cytosolic hexokinase is less 
efficient.32-34 In whole-cell studies on an adenocarcinoma cell line, the levels of specific 
glycolytic intermediates, measured by enzymatic methods, were decreased in a dose-
dependent manner with a compound that increases soluble hexokinase, suggesting that 
larger fractions of cytosolic hexokinase causes less efficient glucose phosphorylation.35 
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Also, one of the cell-free studies with the hybridoma cell line concluded that cytosolic 
hexokinase is more susceptible to inhibition by glucose-6-phosphate.33 And also quite 
interestingly, inhibition of glycolysis with 2-deoxyglucose in rate brain astrocytes 
decreased the amount of mitochondrial hexokinase by 35%, suggesting that 
mitochondrial hexokinase is sensitive to shifts in nutrient availability.15    
 In terms of apoptotic cell death, there are various studies to suggest that 
hexokinase binding to the mitochondria actually plays a role in preventing apoptotic 
protein release, which would certainly indicate that higher rates of glycolysis may signal 
an anti-apoptotic effect since mitochondrial hexokinase is presumably more efficient than 
cytosolic hexokinase. Cell-free studies with isolated HeLa mitochondria treated with 
hexokinase showed that upon addition of Bax, an apoptotic protein that facilitates 
opening of the VDAC and subsequent cytochrome-c release, Bax was unable to bind and 
release cytochrome-c,9 and this same kind of study has also been performed with brain 
mitochondria.36 In in vitro hepatocyte studies, hexokinase IV actually binds to another 
apoptotic protein, Bad, apparently controlling its phosphorylation state (which determines 
protein activity), as determined using immunoprecipitation followed by SDS-PAGE. The 
overall picture presented from the evidence in the aforementioned studies is that when 
hexokinase is bound to the mitochondria, glycolysis is higher, and apoptotic proteins are 
antagonized from binding to the VDAC and facilitating apoptotic protein release, leading 
to apoptotic cell death.     
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Chemically Induced Perturbation of Mitochondrial Hexokinase Binding 
 There are very few studies that investigate chemically induced changes in 
mitochondrial hexokinase binding. Only clotrimazole (CTZ) and bifonazole, calmodulin 
antagonists known to interrupt calcium homeostasis, have been investigated in HeLa, 
myeloma, and carcinoma cell lines as compounds which detach hexokinase from the 
mitochondria.9, 35, 37, 38 These investigations have primarily been done to identify the 
compounds as a potential cancer therapy, primarily since a marked reduction in viability 
was observed after treatment with the compounds. Furthermore, there has been at least 
one study investigating the effects of calcium-mobilizing hormones on mitochondrial 
hexokinase, and it was shown that serotonin, along with other hormones, actually 
increases the amount of hexokinase bound to the mitochondria in muscle by as much as 
2-fold.39 All the aforementioned studies were carried out by treatment of the cells with 
the compound, separation of the mitochondrial and cytosolic fractions, and measurement 
of hexokinase activity in each fraction by enzymatic assays.    
 
Akt/PKB Affects Glycolysis, Cell Survival, and Mitochondrial Hexokinase 
 Although this research does not focus on intracellular signaling molecules, it 
should be noted here that the actions of one particular signaling protein, Akt/Protein 
Kinase B, provide strong supporting evidence for the role of mitochondrial hexokinase in 
maintenance of glucose metabolism and cell survival. The anti-apoptotic effects of 
various intracellular signaling proteins are known to be facilitated by increased glucose 
metabolism, and perhaps subsequently, increased mitochondrial hexokinase activity. 
Specifically, Akt is known to promote survival by increasing mitochondrial membrane 
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potential in FL5.12 cells,40 and its anti-apoptotic effects are dependent on glucose 
availability.41, 42 Active Akt prevents apoptosis even following the activation of apoptotic 
proteins Bid and Bax, in part by increasing mitochondrial hexokinase activity.8, 41-43 
These experiments were performed in fibroblasts over-expressing Akt by assessing 
apoptosis in the presence of active apoptotic proteins and measuring the hexokinase 
activity in sub-cellular fraction via enzymatic methods. This further supports a role for 
higher rates of glycolytic metabolism, perhaps instigated by higher concentrations of 
mitochondrial hexokinase, in cell survival. 
 
Summary of Literature Support for the Specific Research Aims 
 The main literature ideas which support this research plan are summarized in 
Table 1.1. There are 5 main supporting claims that have previously been published: (1) 
decreasing glucose consumption may activate apoptotic cell death, (2) glucose 
consumption is known to decrease over time in batch mammalian cell cultures, (3) 
hexokinase is known to bind to the VDAC on the mitochondria, (4) mitochondrial 
hexokinase is known to phosphorylate glucose more efficiently than cytosolic hexokinase 
in cell-free platforms, and (5) mitochondrial hexokinase binding has been shown to 
prevent Bax translocation and subsequent cytochrome-c release. These primary 
supporting ideas coupled with the fact that there are no solid explanations for the 
phenomenon of decreasing glycolysis and apoptotic cell death in batch mammalian cell 
cultures form the foundation for the experimental strategy outlined in this research 
project.   
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Table 1.1. Summary of Relevant Literature Supporting the Project Aims. Five key 
literature findings supporting the research aims are listed in the left column, and the main 
references are listed to the right.   
 
Primary Supporting Idea References 
Decreasing glycolysis may contribute to 
apoptotic cell death 
Plas, et. al. 200244 
Hammerman, et. al. 200445 
Cohen, et. al. 200246 
Kuznetsov, et. al. 200447 
Downward, et. al. 200348 
 
Glycolysis decreases in batch 
mammalian cell culture 
Ozturk, et. al. 19915 
Goergen, et. al. 19926 
Fitzpatrick, et. al. 199349 
Portner, et. al. 199450 
Neermann, et. al. 19967 
Oh, et. al. 199651 
Doverskog, et. al. 19974 
Quesney, et. al. 200352 
 
Hexokinase binds to the VDAC Nakashima, et. al. 1985, 198653, 54 
 
Mitochondrial hexokinase 
phosphorylates glucose more efficiently 
Widjojoatmodjo, et. al. 199033 
Laterveer, et. al. 199434 
 
Mitochondrial hexokinase binding 
prevents Bax translocation 
Pastorino, et. al. 20029 
Vyssokikh, et. al. 200236 
 
 
Research Strategies 
 
Quantification of Cellular Growth, Death, and Metabolism during High-Viability 
Cultures  
 
 The preliminary phases of this project involved quantification of glycolytic 
metabolism, cell growth, and cell death in high-viability batch hybridoma (CRL 1606) 
cultures. A detailed description of growth, death, and metabolism of this cell line during 
the first two days of batch culture has not previously been determined, although data 
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concerning the metabolic and growth kinetics of various mammalian cell lines is readily 
available. An outline of the available literature is summarized in Chapter II. Despite the 
apparent availability of data, these sources do not precisely investigate the dynamic 
nature of metabolism and how it relates to cell death, and there are no attempts at error 
analysis or analysis of the times of peak metabolism. Consequently, the preliminary 
studies of this project were designed to provide detailed and precise data in terms of cell 
growth, death, glucose consumption, and lactate production in high-viability batch 
hybridoma cultures. For these studies, the events prior to cell death observable in regard 
to cellular membrane permeability (a last stage of death) were of primary interest. This 
study was accomplished by seeding T-flasks (175 cm2 area) or spinner flasks at 2.0 x 105 
cells/mL in a complete maintenance medium (IMDM) and removing a sample of media 
and measuring total and viable cell density every 4 hours until the viability dropped 
below 70%. All collected samples of the medium were stored at -20°C until the 
experiment was complete. All samples were analyzed for metabolite concentrations via 
enzymatic assays less than one week after the experiment. The raw data values of glucose 
concentration, lactate concentration, total cell density, and viable cell density were used 
to calculate the derived quantities of growth rate, death rate, glucose consumption rate, 
and lactate production rate.       
 
Methods for Enzymatic Measurements 
 The measurements of glucose and lactate concentration and hexokinase activity 
were done via enzymatic assays. Enzymatic analysis generally involves the measurement 
of a metabolite/amino acid via an end product from a reaction or series of reactions 
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involving the compound of interest as a substrate. The measurement is usually achieved 
through spectrometry or fluorescence. In a great number of enzymatic assays, one of the 
end products is one of two co-enzymes, nicotinamide adenine dinucleotide phosphate 
(NADPH) or nicotinamide adenine dinucleotide (NAD+), one of which is required for the 
reaction and both of which absorb light at 340 nm. This is the case for both the glucose 
and lactate enzymatic assays and the hexokinase activity assay employed in this study. 
Complete recipes for these assays can be found in Methods of Enzymatic Analysis.55 
However, these assays were formulated for use in 1.0-2.0 mL volumes, and I scaled-
down the assay procedures for use in 96-well plates (200 µL volumes). Complete and 
detailed descriptions for each assay are in Chapter II.    
 
Induced vs. Un-induced Mitochondrial Hexokinase Detachment 
 An assumption in this research is that mitochondrial hexokinase can be detached 
in one of 2 ways: it can be chemically induced, with compounds such as clotrimazole, or 
it can be un-induced, possibly occurring naturally over the course of a culture. Aims I and 
II focus on the effects of induced hexokinase detachment (by clotrimazole) on glucose 
consumption rate and apoptotic cell death in hybridoma cultures. Studying an induced 
system was necessary to determine whether or not hexokinase detachment was in fact a 
mechanism that results in an unfavorable outcome for the cell. If induced hexokinase 
detachment does not exert any effects on glucose consumption or cause cell death, then 
there would be little reason to investigate a possible occurrence of detachment in batch 
cultures. Aim III focuses on the un-induced case, measuring possible changes in the 
fraction of hexokinase bound to the mitochondria over time during the course of batch 
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cultures. The glucose consumption profiles quantified in the preliminary studies were 
used as a guide to select specific sampling times to measure mitochondrial hexokinase 
association in high-viability batch cultures.       
 
Experimental Strategies: Batch and Well Plate Studies 
 The experimental designs in this research plan employ 4 different types of 
cultivation modes: T-flasks (Corning), spinner flasks (Bellco Biotechnology), and 6-well 
and 24-well plates (Nunc). Choice of cultivation mode for each separate experimental 
design was based on (1) the volume of culture that would be needed for the 
measurements and (2) the amount of parent culture that would be available for the 
measurements. The preliminary batch experiments where metabolism and growth and 
death kinetics were quantified were carried out in both T-flasks and spinner flasks.  
Aim I experiments entailed the quantification of average glucose consumption 
over a 4-hour time interval for cells exposed to clotrimazole in an attempt to assess the 
effects of induced hexokinase detachment on glucose consumption rate. These 
experiments were carried out in 24-well plates to allow for a maximum number of 
replicates for each tested concentration, and a specialized low-glucose medium 
formulation (RPMI) was used in the experiments to eliminate the need for sample 
dilution (and accordingly reduce error) for the metabolite assays. A 4-hour time interval 
of study and a high seeding density (1.75 x 106 cells/mL) were chosen in an effort to 
measure a detectable glucose concentration difference for rate calculation and error 
analysis. To quantify the effects of various clotrimazole concentrations (presumably 
inducing various levels of hexokinase detachment) on cell death, experiments were 
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carried out in 6-well plates over a 24-hour period to assess long-term effects of induced 
hexokinase detachment on cell viability and apoptosis. Again, a 6-well plate format was 
chosen as the most logical mode of cultivation based on the culture volume needed for 
this experiment.        
The Aim II experiments were carried out in T-flasks (75 cm2 area). A parent 
culture was split into 2 separate cultures, one receiving clotrimazole treatment and the 
other receiving DMSO solvent only. Cells were seeded at 7.5 x 105 cells/mL, and the 
culture was sampled and fractionated for either a 2 or 4-hour period. Fractionated 
samples were stored at -80°C for later hexokinase activity analysis. Cultivation in well 
plates was not appropriate for these experiments due to the large sampling size and 
frequency, which required relatively larger culture volumes.  
The Aim III experiments were carried out in T-flasks (175 cm2 area) and spinner 
flasks in a similar fashion to the batch cultures in the preliminary studies. However, 
samples for glucose and lactate concentrations were not removed, but fractionated cell 
homogenates were sampled according to a pre-determined time schedule based on known 
profiles of glucose consumption in previous batch culture studies. The fractionated 
samples were stored at -80°C, and hexokinase activity was assayed in all samples 
together less that one week after completion of the experiment.  
The measurements performed in all studies focus specifically on high-viability 
cultures, since it is the premise of this research that commitment to apoptotic death 
potentially occurs prior to the “visible” occurrence of apoptosis (i.e., when cell death is 
apparent by the dye-based methods used in this study).     
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Separation of the Mitochondrial and Cytosolic Fractions 
In order to measure hexokinase activity in the mitochondrial and cytosolic 
fractions, each fraction must be separated using a population of cells (7.5 x 106 to 1 x 107 
total cells). The fractions were separated via centrifugation of homogenates in a sucrose 
buffer, a method based on that of the Pierce Mitochondrial Isolation Kit (#89874) and the 
BioVision Mitochondria/Cytosol Fractionation Kit (#K256-100). This is a well-
characterized method that has been used in various studies for mitochondrial hexokinase 
activity determination and is outlined in a number of laboratory manuals and papers.9, 37, 
43, 56, 57 The method is based on the differences in sedimentation rates of each organelle in 
a gravitational field. The buffers supplied in the kits were not used since they were shown 
to interfere with the enzymatic hexokinase activity assay during assay development 
(components such as CHAPS, HEPES, and EDTA are known to interfere with enzyme 
activity). However, it is known that a sucrose buffer is suitable for this method, which 
does not interfere with the hexokinase enzymatic assay.56 Cell lysis was carried out by 
mechanical homogenation prior to fractionation.   
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CHAPTER II 
 
QUANTIFICATION OF GLUCOSE METABOLISM DURING HIGH-VIABILITY  
BATCH HYBRIDOMA CULTURES 
 
Introduction 
 The physiology of batch mammalian cell cultures in terms of growth, death, and 
metabolism is available in various research articles. However, the quality of the data in 
these published works is not sufficient for quantitative analyses, and there have been no 
instances of statistical analyses describing the times in which maximum rates occur or 
analyses to show that the rates are in fact decreasing. Furthermore, the physiology of the 
particular hybridoma cell line used in this study has not been established during the first 
48 hours in batch culture. The preliminary phases of this project involve the 
quantification of cellular metabolism in high-viability (>70%) batch hybridoma cell 
cultures. The data from these preliminary experiments will be used as a guide for 
selection of key time points in which to study hexokinase activity in the mitochondrial 
and cytosolic fractions in Aim III.  
The major research articles investigating growth and metabolic kinetics in batch 
mammalian cell culture are summarized in Table 2.1. All of these studies report 
decreasing glucose consumption rate prior to cell death in the batch cultures. However, 
none of these studies include an error analysis on the calculated rates, and the quality of 
the data is arguably low, considering samples where removed from the batch only every 
12-24 hours. These studies do not really constitute reliable data sets for proper error and 
statistical analyses, in particular to make quantitative observations concerning peak times 
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for metabolic rates and make observations concerning the relationship between changes 
in metabolism and other physiological descriptors.   
 
Table 2.1. Summary of Literature Quantifying Declining Growth and Metabolism in 
Batch Mammalian Cell Culture. All studies in the table show a phenomenon of 
declining glucose consumption rate prior to cell death in batch cultures. No error analysis 
was performed in any of the studies. Sampling times for metabolites were once or twice 
daily. *NS=Not Specified.  
 
Cell Line Cultivation 
Method 
Sampling 
interval (hrs) 
Error Analysis Reference 
Hybridoma Bioreactor 12 None Ozturk, et. al. 19911 
Hybridoma Bioreactor  12 None Georgen, et. al. 19922 
Hybridoma T-flask 24 None Fitzpatrick, et. al. 19933 
Hybridoma T-flask 24 None Portner, et. al. 19944 
Hybridoma Spinner Flask 12 None Oh, et. al. 19965 
Hybridoma T-flask NS* None Neermann, et. al. 19966 
Hybridoma Bioreactor  NS* None Doverskog, et. al. 19977 
Vero Bioreactor 24 None Quesney, et. al. 20038 
 
 
A phenomenon of increasing metabolism has not been observed in batch 
mammalian cell culture, and decreasing metabolism usually coincides with slowing 
growth rates and/or growth arrest. However, decreasing glycolytic rates in batch 
mammalian cell culture have been documented previously in batch and serum-stimulated 
batch hybridoma cultures where the growth rate was kept at a high level, 2, 7 and the 
uncoupling of growth and metabolism is also demonstrated in the existence of multiple 
steady-states at the same growth rate.7, 9-11 Thus, decreasing metabolism can occur despite 
sustained growth by growth-factor (insulin) stimulation.12 
The purpose of this work is to quantify glucose metabolism (i.e., glucose 
consumption and lactate production rates) and cell growth kinetics during high-viability 
batch hybridoma cultures by gathering precise data in 4-hour time intervals. Not only 
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does the phenomenon of decreasing glycolysis need to be quantitatively and precisely 
measured, it must also be confirmed for this particular hybridoma cell line. Here, a very 
comprehensive data set showing the physiology of four batch hybridoma cultures in 
terms of growth, death, glucose uptake rate, and lactate production rate was gathered to 
quantify the time-profile of metabolism prior to visible cell death. Using mass balance 
equations on extracellular metabolites in conjunction with the concentration 
measurements in the batch cultures, I quantify the profile of glucose uptake and lactate 
production rate in this hybridoma cell line and perform error and statistical analyses to 
show decreasing metabolism. The discovery of an appreciable decrease in metabolic rates 
in the early stages (24 hours or less) of batch cultures will be used to discuss the 
implications in terms of progression to apoptotic cell death. Potential causes of the 
phenomenon of decreasing metabolism are also discussed. 
 
Materials and Methods 
 
Cell Line and Maintenance 
The cell line used was a murine hybridoma (ATCC CRL-1606) that secretes an 
IgG against human fibronectin. During maintenance and all experiments, the hybridomas 
were cultivated in a serum-free, hydrolysate-free IMDM formulation, comprised of 
glutamine-free basal Iscove’s Modified Dulbecco’s Medium (IMDM, Mediatech) and 
supplemented with 4.0 mM glutamine (Mediatech), 10 mg/L insulin (Sigma), 5 mg/L 
holo-transferrin (Sigma), 2.44 µL/L 2-aminoethanol (Sigma), 3.5 µL/L 2-
mercaptoethanol (Sigma), and 10 U/ml penicillin – 10 µg/ml streptomycin (Mediatech). 
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The hybridomas were cultivated in T-flasks (Corning) and maintained in an incubator 
(Forma Scientific) at 37°C, 10% CO2 and 95% humidity during maintenance.  
 
Batch Cultures 
Batch culture experiments were performed in both T-175 cm2 culture flasks 
(Corning) and spinner flasks (Bellco Biotechnology). Initially, the cultures were seeded 
at a density of 2.0 x 105 vcell/mL in complete IMDM and a volume of either 60.0 mL for 
the T-flasks or 500 mL for the spinner flasks. At t=0 (immediately after seeding), 1.0 mL 
was sampled into two separate culture tubes (0.5 mL each), trypan blue cell counts were 
performed (2 slides) with 0.1 mL from each tube, and the remaining culture (0.8 mL) was 
combined into a 1.2 mL micro-centrifuge tube and centrifuged at 200g for 15 minutes 
(Forma Scientific Centrifuge). The supernatant was transferred to another micro-
centrifuge tube and stored at -20°C. The sampling and counting procedure was repeated 
every four hours until the viability dropped below 70%. Between sampling, the cultures 
were incubated at 37°C, 10% CO2, and 95% humidity. Analysis of the supernatants for 
metabolite concentrations was performed after all samples had been collected. Samples 
were stored for less than one week prior to metabolite analysis and were subjected to one 
or less freeze-thaw cycle. All cultures were passaged every 24 hours for at least 2 weeks 
prior to the experiments, except for the batch designated T-48. This inoculum was 
maintained every 48 hours 8 days prior to the experiment.   
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Cell Counting and Apoptosis Determination 
Cell number and viability were determined via trypan blue dye exclusion using a 
hemocytometer. The viability was calculated as the number of viable cells divided by the 
number of total cells. A minimum of 2 slides were counted for each sample. Apoptosis 
was characterized using the acridine orange/ethidium bromide fluorescence assay.13 A 
total of 400 cells were counted for each slide for the determination of apoptosis. The 
percentage of each type of cell, whether it was deemed to be early apoptotic, late 
apoptotic, necrotic, or viable, was determined by dividing the number of each type of cell 
by the total number of cells counted (400). 
 
Enzymatic Assays 
Glucose and lactate concentrations were determined via enzymatic assays based 
on the recipes developed by Bergmeyer and Lowry,14 which I reformulated for use in a 
96-well plate (Nunc) format.15 The glucose assay, developed for a range of 0 to 5 mM, 
consists of the coupled reactions: 
ADPPhosphate6ecosGluATPecosGlu
Hexokinase +−−→+     (2-1) 
+−−+ ++−→+−− HNADPHconatePhosphoglu6NADPPhosphate6ecosGlu PDH6G  (2-2) 
In the first reaction, glucose is phophorylated by hexokinase, and in the second reaction, 
phosphorylated glucose is converted to 6-phosphogluconate, which is accompanied by 
the reduction of NADP. The amount of NADPH formed is proportional to the amount of 
glucose substrate, and the NADPH concentration is detected by UV/vis spectrometry at 
340 nm. A calibration line was set up for glucose concentrations in the range of 0-5 mM, 
and the optical density measurement from the unknown samples was used in the 
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calibration line to calculate the unknown concentration. The assay was carried out in 96-
well plates at room temperature with a reaction volume of 200 µL (30 µL unknown 
sample/standard, 15 µL hexokinase stock, and 155 µL assay buffer). The assay 
components consisted of 12 mM ATP, 2.0 mM NADP+, 0.8 mM MgCl2, 0.4 mM DTT, 
0.5 U/mL hexokinase, and 0.24 U/mL G-6-PDH in a 20 mM tris buffer solution at pH 
8.0. Unknown samples were diluted in glucose-free RPMI medium, and calibration 
standards were made in the same glucose-free RPMI solvent to remove any effects of 
phenol red on the optical density measurement. Dilution factors for the unknown samples 
varied from 4-8X, depending on the expected glucose concentration.         
 The lactate assay was carried out in a similar approach for a range of 0-3 mM. 
The reaction describing this assay is a reduction of lactate to pyruvate accompanied by 
the formation of NADH: 
++ ++→+ HNADHPyruvateNADLactate LDH      (2-3) 
The final assay concentrations for the lactate assay were 9.0 mM NAD+ and 50 U/mL 
LDH in a hydrazine-glycine buffer at pH 9.5. The reaction volume was 200 µL (15 µL 
unknown sample/standard, 10 µL LDH stock, and 170 µL assay buffer). Dilution factors 
for the unknown samples ranged from 2-8X, depending on the expected lactate 
concentration, and dilutions and lactate standards were prepared in DI H2O as a solvent. 
For the both the lactate and glucose assays, the incubation time was 90 minutes. All 
absorbance measurements were performed using a µQuant Microplate Spectrophotometer 
(Bio-Tek Instruments). 
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Calculation Methods: Treatment of Experimental Data 
 Raw concentration and cell density data were used to calculate the specific 
metabolic rates for glucose consumption and lactate production over time in batch 
cultures. The rate is calculated from a mass balance using equation 2-4: 
Vi
i nq
dt
dC =          (2-4) 
where qi is the uptake or production rate of a metabolite i, Ci is the concentration of the 
metabolite, nv is the viable cell density of the culture during the time of analysis, and t is 
the time. If metabolite concentration and growth profiles are known for a batch system 
over a specified amount of time, then a polynomial regression can be performed and the 
first derivative can be used to describe the rate of change of the measured metabolite, and 
thus q can be calculated from equation (2-5). This is the method of calculation that will 
be used in this study.  
)t(n
1*
dt
dC)t(q
V
i
i =         (2-5) 
Growth and death rates are determined from total and viable cell balances (2-6 
and 2-7) 
TVV
T nfn
dt
dn µµ ==         (2-6) 
VdV
V nkn
dt
dn −= µ         (2-7) 
where nT is the total cell density in cells/mL, µ is the growth rate in hr-1, fv is the fraction 
viable (nV/nT), and kd is the death rate in hr-1. Again, since the concentration of total and 
viable cells is known over time, then a polynomial regression can be performed and the 
first derivative used to calculate growth and death rates from equations 2-8 and 2-9:  
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=          (2-8)  
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V
V
d −= µ        (2-9) 
Third or fourth order polynomials (depending on the correlation coefficient) were 
fitted to data for total cell density (cells/mL), viable cell density (vcells/mL), glucose 
concentration (mM), and lactate concentration (mM) using least-squares polynomial fit 
procedures and error analysis based on covariant terms in an error matrix (described 
below). The coefficients for each term in the polynomial were generated, and these 
models were used in the calculations for growth, death, and metabolic rates as a function 
of time.  
The first derivative of the functions describing glucose consumption and growth 
rate were calculated using the product rule (2-10 and 2-11) in order to apply statistical 
methods and calculate the maximum values. 
dt
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Polynomial Fitting and Statistical and Error Analysis 
 Error on the raw data values for cell density was calculated as the standard 
deviation of the 2 slides measured. The error on the raw glucose and lactate concentration 
values was determined by the uncertainty in the calibration line. For the calibration lines 
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on the enzymatic assays, the optical density (OD, corresponding to NADPH or NADH 
concentration) is linearly related to the metabolite concentration C.    
 bmCOD +=          (2-12) 
where m is the slope and b is the intercept. The calibration line does not intercept the 
origin since blank wells do have some absorbance, but the OD of the blank was 
subtracted from each OD value for the standards for calibration purposes. The error on 
any calculated concentration determined from the calibration line is described by 
equation 2-13, 
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ir
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1
r
1
m
s −++=σ        (2-13) 
where sr is the standard deviation about the regression, r is the number of replicates 
measured, n is the number of calibration points, ODi (bar) is the measured quantity, OD 
(bar) is the average optical density from all calibration points, and Sxx is the standard 
deviation of the measured concentrations in the calibration, given by equation 2-14.      
 ∑ −= 2ixx )CC(S         (2-14) 
The calculation method in its entirety can be found in Principles of Instrumental 
Analysis.16  
Polynomial curves were fitted to the raw data values (Cglc, Clac, nT, and nV) using 
a determinant solution method described in Chapters 6 and 7 of Data Reduction and 
Error Analysis for the Physical Sciences.17 The method presented in these chapters is a 
least-squares fit using the method of determinants. In brief, the method sets up a matrix 
solution using the raw data values, and calculates the coefficients of each term of the 
polynomial to a specified degree. For the uncertainty, the chapter includes the calculation 
of an error matrix, the elements of which are the variance and covariance values for each 
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of the coefficients. The error matrix is used to calculate the uncertainty for each value of 
the independent variable. Thus, for any calculated result, the uncertainty can be 
determined from an equation which uses the partial derivatives of the dependent variable 
with respect to each polynomial coefficient. The calculation method is quite lengthy and 
not presented in detail here. The error bars for qglc (glucose consumption), qlac (lactate 
production), µ (growth rate), and kd (death rate) were all derived from this method. The 
degree of the polynomial needed for each raw data set was determined by the value of the 
correlation coefficient (R2) and the significance of each coefficient as determined by 
ANOVA in JMPIN 4.0 software.     
Statistical treatment of the data was accomplished by either Model I ANOVA, 
which analyzes treatment effects, followed by Tukey’s Test or a student’s t-test. 
Normality of the data was verified through calculations of skewedness and kurtosis. 
Statistical tests were done in Microsoft Excel, although all calculations were verified in 
JMPIN 4.0 statistical software. Table 2.2 summarizes the statistical comparisons applied 
to this data set. 
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Table 2.2. Summary of Statistical Techniques Applied to Reduced Batch Data. 
Comparisons were made to statistically show that glucose consumption rate decreases 
early in the batch cultures and prior to decreases in growth rate and viability. 
*MSD=minimum significant difference.  
 
comparison statistical 
test  
sample 
size  
degrees of 
freedom 
basis of 
comparison 
Determination of time 
in which functions are 
statistically decreasing 
 
Model I 
ANOVA/ 
Tukey’s Test 
2 or 3 1 or 2 F statistic; 
MSD* 
Comparison of 
statistically decreasing 
times 
 
Two-sample 
t-test 
8 6 t statistic 
Comparison of peak 
times for qglc and µ 
 
Two-sample 
t-test 
8 6 t statistic 
Comparison of 
difference in peak 
times for qglc and µ 
One-sample  
t-test 
4 3 t statistic 
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Results 
 
Profile of Cell Growth and Metabolism during High-Viability Batch Hybridoma 
Cultures 
 
 Figures 2.1 through 2.4 illustrate the kinetics of growth and metabolism in one 
batch experiment for cells cultivated in a T-flask. Since all the batch experiments 
exhibited very similar physiological phenomena, the experimental data from this one 
experiment is presented in detail, and the results from all 4 replicates are summarized in 
Table 2.2. Figure 2.1 shows the profile of total and viable cell densities for high-viability 
(>70%) batch hybridoma cell cultures. Figure 2.1A is the raw data values with errors 
(standard deviations on the measurements from 2 counted slides). The increasing nature 
of the error bars with time is due to dilution errors during high-density, late-stage culture. 
When a polynomial regression is performed and the error is calculated again, the error 
bars are reduced (Figure 2.1B). In some cases, the data were truncated slightly in order to 
improve the polynomial fit. The average standard deviation for the errors on the raw data 
for the cell counts was about 5.4 x 104, and the average standard deviation for the values 
in the polynomial fit was about 2.2 x 104, which represents over a 50% reduction in error.    
    
 35
0.0E+00
4.0E+05
8.0E+05
1.2E+06
1.6E+06
0 12 24 36 48 60 72
time (hrs)
ce
ll 
de
ns
ity
 (c
el
ls
/m
L)
A
0.0E+00
4.0E+05
8.0E+05
1.2E+06
1.6E+06
0 12 24 36 48 60 72
time (hrs)
ce
ll 
de
ns
ity
 (c
el
ls
/m
L)
B
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.1. Total and Viable Cell Densities of Batch Hybridoma Culture. The raw 
data measurement values (A) for both total cell density (●) and viable cell density (□) are 
somewhat noisy, but this noise is reduced in error estimated from the polynomial fits (B).  
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The profile of growth kinetics in batch hybridoma cultures can also be observed 
in Figure 2.1. The cells exhibit a lag phase of growth, which ends about 12 hours after 
subculture at 2.0 x 105 cells/mL. The cells continue to grow until about 48 hours, when 
the growth rate (or more appropriately, division rate) has slowed considerably and 
apoptotic cell death begins, as evidenced by the deviation in total and viable cell density 
curves. In batch culture, this particular cell line achieves densities ranging from 1.3-3.0 x 
106 cells/mL, depending on the inoculum and mode of cultivation.  
The raw data values for glucose and lactate concentration in this batch culture are 
shown in Figure 2.2, A and C, and the corresponding polynomial fits, 3rd and 4th order for 
glucose and lactate, respectively, are shown in Figure 2.2, B and D. Again, the 
polynomial fit analysis reduces the estimates of errors significantly. The average error on 
the glucose concentration is reduced from 0.41 to 0.17, and the average lactate error is 
reduced from 0.19 to 0.08. The initial presence of a small amount of lactate (~3 mM) is 
the result of passaging.  
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Figure 2.2. Glucose and Lactate Concentration Profiles in Batch Hybridoma 
Culture. Glucose concentration-time data (A) was fitted with a 3rd order polynomial (C), 
and lactate concentration-time data (B) was fitted with a 4th order polynomial (D).  
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Using the polynomial equations for Cglc, Clac, nV, and nT, the growth rate, death 
rate, glucose consumption rate, and lactate production rate were calculated according to 
the mass balance equations. Figure 2.3 illustrates the resulting profile of growth rate and 
death rate in this batch culture. Clearly, growth rate reaches a maximum early in the 
culture and exhibits a decreasing trend throughout the batch. Death rate begins slowly 
ascending after about 48 hours. No real significance is attributed to the non-zero death 
rate at 8-12 hours after subculture, at which time the culture is still in the lag phase of 
growth. Although mammalian cells in culture are known to exhibit primarily apoptotic 
cell death,18-20 the occurrence of apoptosis was verified using the AO/EB assay in the 
spinner flasks and in other T-flask experiments (separate from the experiments shown 
here) for this cell line. By 72 hours after subculture in T-flasks, the cells were 
approximately 60% viable, and 36% apoptotic, and 4% necrotic. And by 52 hours after 
subculture in the spinner flasks, the cells were approximately 37% viable, 59% apoptotic, 
and 4% necrotic.       
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Figure 2.3. Growth and Death Rates in Batch Hybridoma Culture. Growth rate (●) 
peaks early in the culture and steadily declines over the course of the batch. Death rate 
(○) begins slowly ascending after about 48 hours. 
 
 
 
Similar to the profile of growth rate, metabolic rates, specifically glucose consumption 
and lactate production, reach a maximum very early in the batch culture and decrease 
throughout the duration of the batch (Figure 2.4). The absolute magnitude of the 
metabolic rates and the extent of the decrease throughout the batch is a function of both 
the inoculum maintenance schedule and mode of cultivation (Table 2.2).  
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Figure 2.4. Glucose Consumption and Lactate Production Rates in Batch 
Hybridoma Culture. Metabolic rates peak near the end of the lag phase of growth (~12-
20 hours after subculture) and continue to decline until apparent cell death (~48 hours 
after subculture). Metabolic data is shown for glucose consumption (○) and lactate 
production (●) rate.  
 
 
 
 Table 2.3 summarizes the major metabolic and growth rate observations from all 
4 replicate experiments. The inoculum variability between the T-48 flask and the other 
three cultures is quite apparent. Maximum glucose consumption rates occurred between 
15 and 20 hours for all batches, and maximum growth rates occurred after 20 hours. The 
glucose consumption rate decreases about 2.5-3.7X between 15 and 48 hours, depending 
on the inoculum. Lactate production rate, although not listed in the table, decreased much 
more variably, ranging from 4X to 18X lower between 15 and 48 hours depending on 
inoculum, which indicates variable metabolic shift for each culture. These physiological 
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changes occur well in advance of the apparent decreases in viability, which happens 48-
68 hours after subculture.    
 
 
Table 2.3. Summary of Batch Hybridoma Culture Experiments. The peak glucose 
consumption rates were about 5 x 10-10 mmol/vcell/hr. except for the 48-hour inoculum, 
which exhibited much higher metabolism. Errors are the standard deviations calculated 
from the polynomial fits. Peak metabolic rates were determined by setting the first 
derivative of the GUR and growth rate functions to zero. *mmol/vcell/hr x 10-10, **qglc at 
44 hrs is listed here since the data were truncated 
 
experiment  peak qglc * time 
(hrs)
peak µ  
(hr-1) 
time 
(hrs)
qglc at 48 
hours * 
time fv ↓ 
(hrs) 
T-24 Flask 4.70±0.34 15.84 0.056±0.006 20.35 1.71±0.04 64 
T-48 Flask 7.41±0.35 20.65 0.052±0.002 26.97 1.99±0.03 68  
Spinner 1 4.74±0.37 15.67 0.065±0.007 22.88 1.87±0.08** 48  
Spinner 2 5.23±0.34 15.79 0.066±0.005 23.09 2.15±0.05 48  
 
 
 
Statistical Comparisons among Growth, Metabolism, and Cell Death 
 
 Enabled by calculated rates that have improved error estimates, statistical tests 
were performed to garner information on the times in which glucose consumption, 
growth, and viability are reaching a maximum and statistically decreasing. This allows 
for observations to be made concerning the order of physiological events prior to 
apoptotic cell death and also allows for statistical significance of the decreasing nature of 
growth and metabolism prior to cell death to be established. Initially, a Model I ANOVA 
was performed by comparing each time point between 12 and 48 hours for each separate 
experiment. All ANOVA tests were found to be significant based on calculated F values 
that were far greater than the critical F (p<0.0001 in most cases). Tukey’s Test, 
comparing each pair of means, identified the times in which we can say statistically that 
each function was decreasing. The results are summarized in Figure 2.5. Clearly, GUR 
statistically decreases prior to growth rate or viability.          
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Figure 2.5. Comparison of Times in which Glucose Consumption Rate, Growth 
Rate, and Viability Statistically Decrease in Batch Hybridoma Cultures. For each 
separate experiment, comparisons were made among the various time points by one-way 
ANOVA followed by Tukey’s Test. Data shown is the time in which each physiological 
descriptor was statistically lower than the maximum value. Error bars are the standard 
deviations of the 4 replicate experiments. Statistical comparison was performed via a 
one-tailed student’s t-test. The α level was not adjusted to reduce Type I error since the 
comparison of means was not for comparison of specific treatments, but rather 
physiological occurrences. Sample size was 3 for the qglc ANOVA and 2 for both the 
growth rate and viability ANOVA tests. *p<0.0112, **p<0.0025  
 
 
 
Comparison of the peak times of glucose consumption rate and growth rate can be 
performed by either a one-sample or two-sample t-test (Table 2.4). For the two-sample t-
test, the peak times of glucose consumption rate for each flask were averaged, and this 
was also done for the peak times of growth rate. The two means were compared, yielding 
a t-statistic of 3.46 (tcritical=2.45). This was significant at the 99.9% confidence level. For 
the one-sample, the difference in the times of peak glucose consumption and growth was 
calculated for each flask, and the difference was compared to zero. This yielded a t-
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statistic of 9.79 (tcritical=5.84), which is also significant at the 99.9% confidence level. 
Thus, two-different t-tests show that glucose consumption reaches a maximum 
statistically prior to growth rate. 
 
Table 2.4. Summary of Times in which Maximum Growth and Glucose 
Consumption Occur in Batch Hybridoma Cultures. The maximum values were 
determined by setting the derivative to zero and noting the time in which the maximum 
occurs. The data in the table was used for both a one-sample and two-sample t-test. 
Means for the time of peak qglc and µ were compared to each other, and the difference in 
times was compared to zero. **p<0.001    
  
 
experiment time of peak 
qglc (hrs) 
time of peak 
µ (hrs) 
tµ-tqglc 
T-24 Flask 15.84 20.35 4.51 
T-48 Flask 20.65 26.97 6.32 
Spinner 1 15.67 22.88 7.20 
Spinner 2 15.79 23.09 7.30 
Average 16.99±2.44 
 
23.32±2.73** 
 
6.34±1.29** 
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Discussion 
 
 The key findings and observations in this chapter are (1) glucose consumption and 
lactate production are observed to decrease statistically over time in batch hybridoma 
(CRL 1606) cell cultures, (2) decreases in metabolism occur well in advance of apoptotic 
cell death, and (3) glucose consumption rate statistically reaches a maximum prior to 
growth rate. Although growth and metabolic kinetic data has been previously published, 
the application of error analysis by polynomial fitting and statistical analyses on peak 
rates in this project is a novel approach to analyzing physiological data. A second 
approach to function fitting by generalized logistic equations was attempted,21 but did not 
provide acceptable fits to the data by visual inspection and also did not provide any 
method of error analysis, which was essential for this study. Here, I have presented firm 
statistical evidence that glucose consumption rate begins declining before growth rate and 
viability, and this certainly provides a firm basis for speculation that declines in 
metabolism in the early stages of batch culture may contribute to unfavorable 
physiological outcomes, such as apoptotic cell death.      
 This study precisely illustrates a statistical decrease in glucose consumption and 
lactate production very early in batch hybridoma cultures (26 hours after subculture, on 
average), which has not been previously determined. The quantification of decreasing 
metabolism very early after subculture has several implications in terms of the 
progression to apoptotic cell death in batch hybridoma cultures. Literature reviews have 
hypothesized that decreasing glucose consumption may not provide the mitochondria 
with enough substrates to maintain permeability, thus eventually causing apoptotic 
protein release and subsequent death.22, 23  It has also been hypothesized that given the 
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fact that Akt functions to promote cell survival by increasing glucose transporters and 
hexokinase activity in hematoma cells over-expressing Akt,24 apoptotic proteins, such as 
Bax, might function as a metabolic sensor, and when metabolism reaches a certain 
threshold, the apoptotic mechanism is activated.23 This is pure speculation, of course, but 
the fact that we can now prove a statistical decline in metabolism prior to cell death is 
persuasive circumstantial evidence to support such hypotheses for continued studies. 
Statistically, growth rate is reaching a maximum and decreasing after glucose 
consumption, but it should be noted that the growth rate measurement is actually division 
rate. The division rate of the cells may be expected to lag glucose consumption rate since 
cells in the S and G2/M phase will complete the cell cycle in the coming hours, 
presumably allowing growth rate to appear high. A real measure of growth rate is to see 
whether cells in G0/G1 actually are growing more slowly or not, but this was not pursued 
in this study. So, there might actually not be an uncoupling of growth and metabolism in 
this cell line for the batch mode of cultivation, although we do statistically observe an 
apparent uncoupling using the measurements of this particular data set.     
 Glutamine is known to be the second largest carbon source for mammalian cell 
lines after glucose.25 To verify that glutamine consumption is not increasing to 
compensate for the decrease in glucose consumption, glutamine/glutamate was measured 
in the spinner flask cultures (data not shown). The calculated rate exhibited the same 
peak followed by a steady decrease, identical to the glucose and lactate rates.  
Changing environmental conditions, such as pH and osmolality, are known to 
contribute to decreasing glucose consumption rate.26-28 The pH and osmolality in batch T-
flask cultures was measured in this study (albeit in separate T-flask cultures from the 
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metabolic studies), and osmolality decreased only 6 mOsm/kg solvent between 
subculture and 48 hours. The pH decreased from 7.3 at subculture, to 7.14 at 24 hours, to 
6.92 at 48 hours. A study regarding the effects of pH on glucose uptake rate in continuous 
steady-state hybridoma cultures found little dependence on glucose uptake for pH values 
7.0 and above,26 and the pH in the cultures in this study remains above 7.0 for most of the 
batch. Thus, during the beginning of the decline in metabolism, pH was presumably 
stable. 
It should be noted that the magnitude of metabolism is not necessarily a factor 
here, nor is the presence or absence of metabolic shift as evidenced from calculation of 
the qlac/qglc ratio for each batch. In fed-batch studies, glucose metabolism is maintained at 
lower levels, and in fact this feeding maintains viability a bit longer despite reduced 
glucose metabolism.29 Thus, regardless of inoculum variations and feeding of nutrients, 
the phenomenon of metabolic decline still occurs in advance of cell death.  
 The findings in this chapter suggest a possible role for declining metabolism in 
the activation of the apoptotic pathway since glucose consumption is indeed observed to 
be declining along with or in advance of declining growth and in advance of death. The 
question as to what is causing such a decline remains, and there are numerous possible 
hypotheses for this question. This research project moved forward to investigating one 
possible cause: hexokinase detachment from the mitochondria. Interestingly during some 
preliminary work, I discovered that this cell line is sensitive to an indirect Akt inhibitor, 
LY294002. Supplementation of the culture medium with this compound caused apoptotic 
cell death as evidenced by AO/EB and decreased glucose consumption in 4-hour 
metabolic rate screens in concentrations up to 10 µM (data not shown). The Akt pathway 
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is known to exert cell protective effects by increasing cellular metabolism, and the fact 
that this cell line is sensitive to inhibition of this pathway suggests that the pathway is 
active in this cell line and it plays a role in cell survival and homeostasis. And 
intriguingly, it has been reported that addition of LY294002 in MEF cell lines also 
decreases mitochondrial hexokinase activity.30 This work implied a susceptibility of the 
hybridoma cells to mitochondrial hexokinase detachment. In conclusion, decreasing 
glucose consumption and susceptibility to LY294002 provided the basis for my 
investigation of hexokinase detachment in hybridoma batch culture and its possible role 
in declining glycolysis and apoptotic cell death.    
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CHAPTER III 
 
EFFECTS OF CLOTRIMAZOLE ON MITOCHONDRIAL HEXOKINASE 
ACTIVITY, GLYCOLYSIS, AND APOPTOSIS  
IN HYBRIDOMA CULTURES  
 
Introduction  
Despite the implications of mitochondrial hexokinase playing a significant 
regulatory role in both glycolytic and apoptotic pathways, published research evaluating 
the in vitro physiological effects of intracellular hexokinase re-distribution between the 
mitochondrial and cytosolic fractions is sparse. In 1992, a published work investigated 
the response of rat diaphragm muscle to calcium-immobilizing hormones via treatment, 
separation of the fractions, and enzymatic assay of hexokinase activity and found that 
mitochondrially bound hexokinase was increased.1 A follow-up study by Penso and 
colleagues evaluated the effects of calmodulin antagonists clotrimazole and bifonazole on 
mitochondrial hexokinase activity in melanoma cells and discovered that interruption of 
calcium transport imparted the opposite effect and mitochondrial hexokinase activity was 
decreased.2 Clotrimazole has since been utilized in cell free platforms to study the 
response of mitochondria to hexokinase detachment in terms of permeability and 
apoptotic protein release and also to illustrate the requirement of mitochondrial 
hexokinase in the anti-apoptotic effects of Akt.3, 4 Clotrimazole has additionally been 
used to exhibit the inhibition of Bax-dependent apoptotsis by mitochondrial hexokinase 
binding.4        
It has been shown that clotrimazole treated carcinoma cells exhibit decreased 
amounts of glycolytic intermediates, namely glucose 1,6-bisphoshpate and fructose 1,6-
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bisphosphate, and ATP levels in a dose and time-dependent manner via treatment and 
enzymatic assay of the intermediates.5 This suggests a decrease in glycolytic activity, 
although glucose consumption rates were not evaluated in this study. And the effects of 
hexokinase gene transfection on growth rate and average lactate production have been 
evaluated for an NID-3T3 cell line, and growth rate appears to be slightly enhanced while 
the average lactate production rate increased 2-fold, suggesting increased glycolysis.6 The 
amount of HK in the mitochondrial fraction also increased 2-fold while the increase in 
cytosolic HK was nominal, indicating that mitochondrial HK has large glycolytic control 
in this cell line. The effects on glucose consumption were also not evaluated in this study. 
Although cell-free studies on isolated mitochondria show that hexokinase more 
efficiently phosphorylates glucose when attached to the mitochondria, there are no in 
vitro studies to support such a claim.7-9 If mitochondrial hexokinase is more efficient than 
cytosolic hexokinase (i.e., lower Km value and less inhibition by glucose-6-phosphate), 
then detaching hexokinase from the mitochondria in vitro would cause a measurable 
decrease in glucose consumption in cases where the enzyme exerts a high level of control 
on the pathway. And since metabolic control through fed-batch cultivations is widely 
used in industry, these results have particular relevance to bioprocesses since perturbation 
of mitochondrial hexokinase could potentially serve as a target to control glycolysis.   
Furthermore, if mitochondrial hexokinase plays a role in maintaining VDAC 
closure and preventing apoptotic protein release, then detachment of this enzyme in vitro 
would induce apoptotic cell death. A dose-dependent decrease in viability as determined 
by trypan blue dye exclusion has been documented for clotrimazole treated melanoma 
and carcinoma cultures,2, 5, 10 although the mode of death has not been quantified. 
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Additionally, the kinetics of induced mitochondrial hexokinase detachment by 
clotrimazole have not been evaluated on any cell line. 
The activity of the bax-induced pathway or the function of mitochondrial 
hexokinase is not known for the hybridoma CRL 1606 cell line. The general objective of 
this work is to explore the activity of the bax-induced apoptotic pathway in CRL 1606 
and quantify the effects that perturbation of this pathway has on cell death and glycolysis 
by inducing mitochondrial hexokinase detachment. If the Aim III studies show that 
hexokinase is indeed becoming detached during batch culture, then the effects that this 
detachment has on death and glucose consumption must be quantified to make the claim 
that such an occurrence in batch cultures is detrimental to the cells. Here, clotrimazole 
will be used as a probe to induce hexokinase detachment. If it is shown that clotrimazole 
treatment exerts no effect on this cell line, this would indicate that either clotrimazole 
does not detach hexokinase from the mitochondria or the cells do not require hexokinase 
to be bound to the mitochondrial to maintain homeostasis. In the following studies, I 
induce mitochondrial hexokinase detachment in hybridoma cultures via supplementation 
of clotrimazole to the culture medium and measure apoptotic morphology and calculate 
short-term glucose consumption rates. I also verify the antagonistic effects of 
clotrimazole on mitochondrial hexokinase binding. These experiments satisfy Aims I and 
II of this research project. Results are used to discuss the potential role of mitochondrial 
hexokinase in the regulation of glycolysis and apoptotic cell death.    
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Materials and Methods 
 
Cell Line and Maintenance 
The cell line used was a murine hybridoma (ATCC CRL-1606) that secretes an 
IgG against human fibronectin. During maintenance and all experiments, the hybridomas 
were cultivated in a serum-free, hydrolysate-free IMDM formulation, comprised of 
glutamine-free basal Iscove’s Modified Dulbecco’s Medium (IMDM, Mediatech) and 
supplemented with 4.0 mM glutamine (Mediatech), 10 mg/L insulin (Sigma), 5 mg/L 
holo-transferrin (Sigma), 2.44 µL/L 2-aminoethanol (Sigma), 3.5 µL/L 2-
mercaptoethanol (Sigma), and 10 U/ml penicillin – 10 µg/ml streptomycin (Mediatech). 
The hybridomas were cultivated in T-flasks (Corning) and maintained in an incubator 
(Forma Scientific) at 37°C, 10% CO2 and 95% humidity during maintenance.  
 
Analytical Techniques 
 
Cell Counting and Apoptosis Determination 
Cell number and culture viability were determined via trypan blue dye exclusion 
using a hemocytometer. Culture viability was calculated as the number of viable cells 
divided by the number of total cells. A minimum of 2 slides were counted for each 
sample. Apoptotic morphology by the presence of DNA fragmentation was characterized 
using the acridine orange/ethidium bromide fluorescence assay.11 A total of 400 cells 
were counted for each slide for the determination of apoptosis. The percentage of each 
type of cell, whether it was deemed to be early apoptotic, late apoptotic, necrotic, or 
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viable, was determined by dividing the number of each type of cell by the total number of 
cells counted. Differentiation of each cell type was determined by the visual inspection of 
fragmented DNA and color.  
 
Enzymatic Assays 
 Glucose concentrations for the metabolic rate screening experiments were 
determined enzymatically via the exact method previously described in Chapter II. 
Samples were not diluted since the highest expected glucose concentration was 4.0 mM, 
which is less than the detection limit of 5.0 mM.         
Hexokinase activity in the mitochondrial and cytosolic fractions was determined 
enzymatically using previously described methods which I re-formulated for use in a 96-
well plate format.12 The reaction scheme for the assay is the same as the glucose assay 
(equations 2-1 and 2-2 in Chapter II). The final concentrations of components in the 
assay buffer were 216 mM glucose, 1.1 mM ATP, 1.2 mM NADP, 10 mM MgCl2, and 
1.0 U/mL G6PDH in 40 mM triethanolamine buffer (pH=8.0). After addition of 15 µL of 
undiluted sample to 155 µL of assay buffer, the reaction was initiated by the addition of 
30 µL of 1.44 M glucose solution (in triethanolamine buffer). The absorbance, which 
corresponds to the concentration of NADPH, was measured every minute over a 10-
minute period at a 340 nm wavelength using the kinetic feature on a µQuant UV/vis plate 
reader (Bio-Tek Instruments). The concentration of NADPH in the sample was 
determined by Beer’s Law, 
bCA ε=          (3-1) 
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where A is the measured absorbance of the well, ε is the emissivity of NADPH at 340 nm 
(6.22 mM-1cm-1), b is the path length of the well (0.606 cm) and C is the concentration of 
NADPH (mM). Samples were analyzed in triplicate at room temperature (25°C). 
Hexokinase activity (units) at the specified conditions was calculated as the initial 
velocity of the reaction (i.e., slope of the resulting line), which has the units of µmol of 
NADPH formed per minute per liter of reaction volume in the well at 25°C and pH 8.5. 
 
Cell Fractionation 
Mitochondrial and cytosolic fractions were separated via centrifugation of 
homogenates in a sucrose buffer. First, 7.5 x 106 total cells were sampled and centrifuged 
for 15 minutes at 200g and 25°C to pellet the cells, the spent medium was removed, and 
the cells were re-suspended in 200 µL ice-cold 250 mM sucrose buffer (pH=7.2, prepared 
in PBS) supplemented with 10 µL/mL buffer Halt® protease inhibitor cocktail (Pierce). 
Next, the cells were homogenized for 2 minutes using a Kontes homogenizer. The 2-
minute time was verified as the minimum time necessary for complete cell lysis. The 
lysate mixture was then centrifuged at 700g for 10 minutes and 4°C to pellet cell debris 
(nuclei, membranes, etc..), and the supernatant was removed and transferred to an 
additional tube. The cell debris was discarded. The sample was then centrifuged again for 
15 minutes at 12,000g and 4°C to pellet the mitochondria. The supernatant (cytosolic 
fraction) was transferred to another tube, and the mitochondrial fraction was re-
suspended in 100 µL sucrose buffer. Samples were stored at -80°C for later hexokinase 
activity analysis. 
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Experimental Procedures 
Clotrimazole (CTZ, Sigma), a specific inhibitor of Ca2+-activated potassium 
channels, was used to induce hexokinase detachment from the mitochondria. 
Clotrimazole has been identified as a calmodulin antagonist, which disrupts intracellular 
calcium homeostasis, including calcium transport in the mitochondria. This calcium 
transport is necessary for enhanced mitochondrial hexokinase binding.13-15 Admittedly, 
clotrimazole may have other unknown effects on intracellular homeostasis, but this 
approach is the most direct way known to detach hexokinase. A 25 mM clotrimazole 
stock was prepared in dimethyl sulfoxide (DMSO, Sigma) and used for all experiments. 
All cultures received 0.08% (v/v) DMSO regardless of clotrimazole concentration for all 
experiments except the resazurin reduction viability experiment.  
 
Verification of Hexokinase Detachment by Clotrimazole 
The kinetic measurements of hexokinase activity in the mitochondrial and 
cytosolic fractions for clotrimazole concentrations from 0 to 20 µM were performed in T-
75 cm2 culture flasks (Corning). Test medium stocks with 2X the amount of clotrimazole 
to be tested were prepared in complete IMDM maintenance medium. The flasks were 
seeded at an initial volume of 24.0 mL and a density of 1.0 x 106 vcells/mL by adding 
12.0 mL of a 2.0 x 106 vcell/mL culture to 12.0 mL of the test medium stock. The seeding 
culture was obtained from a 1.0 x 106 vcell/mL parent flask by centrifuging the contents 
of the flask at 200g for 15 minutes (Forma Scientific Centrifuge), removing the spent 
media, and re-suspending with complete IMDM. Immediately after seeding, 7.5 mL of 
culture from each flask was sampled from each flask and fractionated. The flask was 
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incubated at 37°C, 10% CO2 and 95% humidity, and the sampling and fractionation 
procedures were repeated at 1 hour and either 2 hours or 4 hours after seeding. After 
fractionation, the mitochondrial and cytosolic fractions were stored at -80°C for later 
hexokinase activity analysis. Each concentration was tested in triplicate with a separate 
control.      
 
Metabolic Rate Screening (MRS) 
The metabolic rate screening experiments were performed as previously 
described.16 Briefly, hybridoma cells were cultivated in T-175 cm2 flasks, centrifuged at 
200g for 10 minutes, and re-suspended in a low-glucose RPMI 1640 test medium (Sigma) 
containing various concentrations of clotrimazole (8 to 16 µM). These concentrations 
were chosen as a subset of the 2-20 µM range previously tested in an attempt to cause the 
most amount of detachment with the least amount of cell death in a 4-hour period. The 
RPMI test medium was fully supplemented similar to the IMDM maintenance medium. 
The cells were then seeded into a 24-well plate at a density of 1.75 x 106 vcells/mL and 
incubated for 4 hours at 37°C, 95% humidity, and 10% CO2. Samples for initial 
concentrations of glucose were removed from the cultures used to seed the well plate. 
Samples from each well were removed after 4 hours, placed in separate micro-
centrifuged tubes, centrifuged, and supernatants were transferred to a new set of micro-
centrifuge tubes. All samples were stored at -20°C for later glucose concentration 
analysis. Cell counts were performed by trypan blue dye exclusion on 2 wells of each 
concentration at the conclusion of the experiment. The experiment was performed 4 
times, for a total of 16 replicates for each clotrimazole concentration. This experimental 
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platform is more desirable than T-flask studies because it provides quick, multi-replicate, 
quantitative information concerning the metabolic effects of clotrimazole.     
 
Determination of Culture Viability 
The initial viability measurements using trypan blue dye exclusion and AO/EB 
for a 0-30 µM clotrimazole concentration range and 4-hour exposure period were 
performed in 24-well plates (Nunc) as part of a metabolic rate screening experiment as 
described above. The results of the metabolic screen for these concentrations are not 
presented in this study, but the viability measurements are presented to illustrate cell 
death by the trypan blue marker. Measurement of cell viability using resazurin reduction 
was performed in 96-well plates (Nunc) at a density of 7.5 x 105 cells/mL and 
clotrimazole concentrations of 0-30 µM using previously published methods.17 The 
apoptosis measurements by AO/EB were performed in triplicate in 6-well plates (Nunc). 
Test medium stocks were prepared in the same manner as the MRS experiments above, at 
2X the concentration to be tested. Cells were seeded at a volume of 2 mL and a density of 
7.5 x 105 vcells/mL by adding 1.0 mL of culture to 1.0 mL of 2X test medium stock. The 
seeding culture was obtained from an ~8 x 105 vcells/mL parent flask by centrifuging the 
contents of the flask at 200g for 15 minutes, removing the spent media, and re-
suspending with complete IMDM. At 2, 4, 8, and 16 hours after seeding, a volume of 100 
µL was removed from each well and separately mixed with AO/EB dye for counting.  
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Calculation Methods 
 
Intracellular Hexokinase Balance 
To equate the hexokinase concentrations between the mitochondrial and cytosolic 
fractions and derive the relationship between the measured activities in the buffer to the 
intracellular activities, the molar amounts of hexokinase in each fraction must be 
determined and related to the molar amounts in the assay buffer. A mass balance can be 
written on the total intracellular hexokinase: 
mtmtHKTccHKTtHKT SCnVCnCn +=       (3-2) 
where nT (cells/mL) is the number of total cells, CtHK (mmol/cell) is the total 
concentration of hexokinase, CcHK (mmol/Lcytosol) is the concentration of hexokinase in 
the cytosol, Vc (Lcytosol/cell) is the volume of cytosol, CmtHK (mmol/cm2) is the 
concentration of hexokinase per area of mitochondria, and Smt (cm2/cell) is the area of 
mitochondria. The first term on the right side of equation 3-2 represents the amount of 
unbound hexokinase, and the second term represents the amount of bound hexokinase (in 
total moles). Thus, the ratio of bound hexokinase to total hexokinase can be described by 
equation 3-3. 
mtmtHKTccHKT
mtmtHKT
SCnVCn
SCn
HKtotal
HKbound
+=       (3-3) 
Below, I will derive how I can relate this relationship to the reaction kinetics of the 
hexokinase activity assay. 
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Reaction Kinetics for the Hexokinase Activity Assay 
 For the reaction in the sucrose buffer, we can assume Michaelis-Menten kinetics 
for the rate of disappearance of the glucose substrate, 18 
glcm
glcmaxglc
CK
CV
dt
dC
+=−         (3-4) 
where Cglc (mM) is the concentration of glucose, Vmax (mM/min) is the maximal velocity 
of the reaction, and Km (0.1 mM) is the Michaelis constant for glucose.12 At sufficiently 
high substrate concentrations (>>Km), the rate of disappearance of glucose is 
approximately equal to the maximal velocity. 
 max
glc V
dt
dC ≅−           (3-5) 
But the rate of glucose disappearance is equal to the rate of NADPH formation by mass 
balance (1:1 molar ratio), assuming that the second reaction is non-limiting (see equation 
2-2). 
 
dt
dNADPH
dt
dCglc =−         (3-6) 
Furthermore, the initial rate of the reaction, Vmax, is proportional to the enzyme 
concentration, E, by a reaction constant, k.18 
 kEVmax =          (3-7) 
So combining equations 3-5, 3-6, and 3-7, we get 
kE
dt
dNADPH =          (3-8) 
 Equation 3-8 is an expression for the concentration of hexokinase enzyme, E, 
valid in both the mitochondrial and cytosolic fractions. We can also multiply each side of 
equation 3-8 by the volume to get the total moles of enzyme: 
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  kEV
dt
dNADPHV bufferbuffer =        (3-9) 
 
Relating Assay Measurement to Intracellular Hexokinase Concentration 
The total moles from equation 3-9 are equivalent to the total moles from the 
intracellular hexokinase balance in 3-3. 
cytobuffermitobuffer
mitobuffer
mtmtHKTccHKT
mtmtHKT
kEVkEV
kEV
SCnVCn
SCn
HKtotal
HKbound
+=+=    (3-10) 
Substituting equation 3-8 into 3-10, we get 
cytobuffermitobuffer
mitobuffer
NADPHVNADPHV
NADPHV
HKtotal
HKbound
∆∆
∆
+=     (3-12) 
Equation 3-12 describes the calculation for the relationship between the mitochondrial 
bound and total hexokinase concentrations, which will be valid only for the measurement 
of the initial reaction rates. If the buffer volume is the same for each fraction, then Vbuffer 
will cancel out of the equation. It should be noted that the dilution factor for the addition 
of sample into the assay buffer in the well plate was also considered. In the hexokinase 
activity assay, the change in NADPH is measured, and the volume of the buffer for each 
fraction is known. Thus, the fraction bound is calculated by equation 3-12. It should be 
noted that during assay development, the sum of the measured activities in the fractions 
was tested against the total activity in a sample that was not fractionated, and the results 
were consistent.      
 
Rate Calculations for Metabolic Rate Screening (MRS) 
Rates for each well of the metabolic screening experiment were calculated as the 
change in concentration divided by the viable cell density of the seed culture and the time 
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interval of 4 hours. Average rates for control and clotrimazole-supplemented cultures 
were taken as the average and standard deviation from a conglomeration of 16 wells (4 
wells from each of the 4 replicate experiments).  
 
Error Analysis and Statistical Methods 
Statistical treatment of the clotrimazole-induced mitochondrial hexokinase 
detachment experiments was accomplished by multivariate ANOVA and Model I 
ANOVA followed by the Tukey-Kramer Method. The outcome of the multivariate 
ANOVA is an F statistic, which is compared to a critical F value to determine statistical 
difference for each source of variation. The Tukey-Kramer Method compares all sets of 
means to each other using the calculated minimum significant difference (MSD). If the 
difference in any pair of means is greater than the MSD, then the means are said to be 
statistically different.        
Statistical treatment of the metabolic rate screening data was accomplished by (1) 
randomized block analysis to test for any potential influence of inoculum variations on 
the calculated glucose consumption rate and (2) Model I ANOVA followed by either 
Dunnett’s Test to test the effects of clotrimazole on glucose consumption rate as 
compared to the control or the Tukey-Kramer Method. A significant F value from the 
ANOVA indicates that there is a significant difference between the means of 2 or more 
groups at the 95% confidence level. In the randomized block, F values were generated for 
both the inoculum and CTZ and then compared to a critical F value based on the degrees 
of freedom. For the follow-up Dunnett’s Test, a value for the minimum significant 
difference is calculated based on the mean square within and compared to the differences 
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in the means of each test group and the control. If the difference in means is greater than 
the minimum significant difference, then there is a statistically significant difference in 
the means.    
Errors on the trypan blue and resazurin reduction viability measurements were 
calculated as the standard deviation of 2 independent replicates. Errors on the fraction of 
each cell type determined by AO/EB were calculated as the standard deviation from 3 
independent replicates. Comparison of viabilities for each concentration at each time 
point was done using Model I ANOVA followed by the Tukey-Kramer Method. All 
calculations and statistical tests were performed using Microsoft Excel and the results of 
the statistical tests were verified using JMP 4.0 statistical software. 
 
Results 
 
Clotrimazole Decreases the Fraction of Hexokinase Bound to the Mitochondria in 
Hybridoma Cultures  
 
The experiments quantifying the kinetics of hexokinase detachment from the 
mitochondria by clotrimazole treatment involved 3 different sources of variance: 
inoculum, time, and clotrimazole treatment. Initially, the effects of all 3 sources of 
variation on the fraction of total hexokinase bound to the mitochondria were determined 
statistically using multivariate ANOVA (Table 3.1). The effects of both time and 
clotrimazole treatment are significant sources of variation. The 2 and 15 µM 
concentrations showed a significant inoculum variation.      
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Table 3.1. Multivariate ANOVA Results for Aim II Experiments. The effects of 
clotrimazole treatment, time, and inoculum were tested. The effects of inoculum were 
insignificant for 2, 10 and 20 µM concentrations, while the effects of clotrimazole 
treatment and time were largely significant for all concentrations. *p<0.05 
 
 
 
 
A portion of hexokinase does bind to the mitochondria in hybridoma CRL 1606 
cultures, as indicated by the in vitro measurement of hexokinase activity in the 
mitochondrial fraction. That portion is estimated to be between 20% and 30% of the total 
amount of hexokinase, which corroborates estimates for another hybridoma cell line.7 
Furthermore, clotrimazole reduces the amount of hexokinase associated with the 
mitochondrial fraction (Figures 3.1 and 3.2). For the 0+ and 1 hour time points, the 
fraction of hexokinase bound to the mitochondria was statistically similar across the 0-5 
µM concentration range (Figure 1A). However by 4 hours after exposure, there is a dose-
dependent trend in the fraction of hexokinase bound to the mitochondria among the 0, 2, 
and 5 µM concentrations according to the Tukey-Kramer Method, which indicated 
statistical difference among the means at the 95% confidence level. Furthermore, the 0 
and 2 µM concentrations exhibited a statistically significant increase in total hexokinase 
activity between 1 and 4 hours (Figure 1B). The 5 µM concentration exhibited 
statistically constant values for both fraction bound and total hexokinase activity over the 
0-4 hour time interval studied.         
 F statistics 
clotrimazole 
(µM) 
treatment time inoculum 
2 24.4* 26.3* 0.8 
5 406.7* 13.0* 50.0* 
10 2090.4* 91.3* 2.6 
15 1378.8* 26.9* 33.6* 
20 311.8* 10.5* 0.4 
 67
 
Figure 3.1. Fraction of Hexokinase Bound to the Mitochondria and Total 
Hexokinase Activity during 4-Hour Exposure to 0, 2, and 5 µM Clotrimazole. 
Statistical analysis with the Tukey-Kramer Method reveals that there is statistical 
difference in the fraction of hexokinase bound to the mitochondria among the 0, 2, and 5 
µM concentrations 4 hours after exposure (A), but clotrimazole treatment did not affect 
the total hexokinase activity (B). Error bars represent the standard deviation of three 
replicates. Data is shown for 0+ (black bars), 1 hour (white bars), and 4 hours (grey bars) 
after clotrimazole exposure.    
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 Figure 3.2 illustrates the fraction of hexokinase bound to the mitochondria and the 
total hexokinase activity for cultures exposed to 0, 10, 15, and 20 µM clotrimazole over a 
2-hour period. For these larger concentrations, there is no dose-dependency in the 
fraction bound among the 10, 15, and 20 µM concentrations for any of the time points 
studied as determined by comparison of means from the Tukey-Kramer Method (Figure 
3.2A). The fraction of hexokinase bound to the mitochondria for all tested concentrations 
was statistically decreased from the control to a level of about 10%. Clotrimazole 
treatment did not exert any effect on the total hexokinase activity (Figure 3.2B), but it 
should be noted that the control cultures and the 2 µM clotrimazole-treated culture from 
Figure 3.1B exhibited a small decrease in total hexokinase activity 1 hour after exposure 
and then an increase 2 or 4 hours after exposure.      
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Figure 3.2. Fraction of Hexokinase Bound to the Mitochondria and Total 
Hexokinase Activity during 2-Hour Exposure to 0, 10, 15, and 20 µM Clotrimazole. 
Statistical analysis with the Tukey-Kramer Method reveals that there is no statistical 
differences in the fraction of hexokinase bound to the mitochondria among the 10, 15, 
and 20 µM concentrations 2 hours after exposure (A), but the fraction of hexokinase 
bound to the mitochondria for each concentration was statistically decreased from the 
control. Total hexokinase activity remained fairly constant over the 2-hour time interval 
(B). Error bars represent the standard deviation of three replicates. Data is shown for 0+ 
(black bars), 1 hour (white bars), and 2 hours (grey bars) after clotrimazole exposure.     
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Clotrimazole Causes Decreased Average Glucose Consumption Rate over a 4-Hour 
Interval 
 
Previous studies have reported dose-dependent decreases in glycolytic 
intermediates for carcinoma cells exposed to clotrimazole concentrations up to 50 µM for 
0.5-2 hours.5 However, here I show that the average glucose consumption rate as a 
function of clotrimazole concentration over a 4-hour period is decreased 12-22% in a 
dose-independent manner for an 8-16 µM concentration range (Figure 3.3). The 
concentrations were chosen as a subset of the 2-20 µM range in an attempt to produce a 
large decrease in mitochondrial hexokinase activity in conjunction with the largest 
observable effects on glucose consumption. A randomized block analysis of the data 
yielded F values of 4.9 and 13.2 for the inoculum and clotrimazole, respectively. 
Comparing to the critical F values of 8.7 and 9.7, respectively, it is clear that the changes 
in glucose consumption can be attributed solely to clotrimazole treatment since the 
effects of inoculum are insignificant. The results of a Model I ANOVA yielded an F 
value of 11.1, and compared to the critical F of 2.33, this shows there is a significant 
difference between two or more means of the test groups. A follow-up with Dunnett’s 
test confirmed that all experimental test groups are significantly different from the control 
with 95% confidence. Furthermore, a follow-up with the Tukey-Kramer Method did 
reveal that the 12 µM concentration caused a statistically decreased glucose consumption 
rate as compared to the other concentrations, but the difference was relatively small.  
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Figure 3.3. Average Glucose Consumption Rate as a Function of Clotrimazole 
Concentration over a 4-Hour Time Interval. Hexokinase detachment induced by CTZ 
leads decreased glucose consumption in this hybridoma cell line. The decrease ranges 
from about 12 to 22% and does not follow a dose-dependent trend. All test cultures 
exhibited glucose consumption that was statistically decreased from the control. *p<0.05, 
†16 µM treatment resulted in viabilities significantly decreased from the control after 4 
hours 
 
Clotrimazole Causes Cell Death Exhibiting Apoptotic Morphology 
 
 The effects of clotrimazole on cell viability were quantified using 3 different dyes 
to make a comprehensive assessment of cell death: trypan blue dye exclusion, resazurin 
reduction (Alamar Blue), and AO/EB. The trypan blue dye assessment was used for an 
initial short-term (4 hour exposure) measurement of viability for a concentration range of 
0-30 µM, and the data show significant decreases in viability for the 15, 20, and 30 µM 
concentrations at the 95% confidence level (Table 3.2). This data was additionally 
assessed with AO/EB after the trypan blue counts. The 30 µM concentration proved to be 
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a particularly lethal dosage, resulting in approximately 60% necrosis after 4 hours 
(AO/EB data not shown).      
 
Table 3.2. Trypan Blue Viability of Hybridoma Cultures Treated with Varying 
Clotrimazole Concentrations. Cells were cultivated in 24-well plates as part of an MRS 
experiment. Statistical treatment was performed with Model I ANOVA followed by 
Dunnett’s Test. *p<0.05    
 
Clotrimazole 
(µM) 
Viability 
0 0.97±0.003 
5 0.94±0.011 
10 0.93±0.001 
15 0.84±0.008*
20 0.67±0.072*
30 0.12±0.003*
 
 
Subsequent testing of viability focused on clotrimazole concentrations from 0 to 
20 µM since the 30 µM concentration caused a significant amount of death exhibiting 
necrotic morphology (i.e., absence of fragmented DNA). Cell death was further 
quantified using resazurin reduction after 16 hours of exposure (Figure 3.4). Clearly, 
there is a dose-dependency for culture viability after this exposure time.   
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Figure 3.4. Viability by Resazurin Reduction of Hybridoma Cultures Treated with 
Varying Clotrimazole Concentrations. Data shown is for a 16 hour exposure. The 
black circles represent the raw data points, and the black line represents the best fit line.    
 
 
 
 Lastly, cell viability was determined over a 16-hour exposure time using the 
AO/EB fluorescence assay to again verify dose-dependent decreases in viability for 
clotrimazole treatment and also to qualify the presence of apoptotic morphology (Figure 
3.5). Again, dose-dependent decreases in viability as determined by the Tukey-Kramer 
Method are witnessed. And from Figure 3.5B, it was determined that the primary mode 
of cell death was apoptosis based on the presence of DNA fragments in the majority of 
the dead cells counted. The 15 and 20 µM concentrations did exhibit some necrosis, but 
on average less than 15%.      
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Figure 3.5. Viability by AO/EB of Hybridoma Cultures Treated with Varying 
Clotrimazole Concentrations. Data shown is after 2 (●), 4 (■), 8 (○), and 16 (□) hours 
of exposure. The overall viability (A) is reduced in a dose- and time-dependent manner. 
Based on the appearance of fragmented DNA, most cell death was deemed apoptotic (B).       
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Discussion 
The results presented here reveal that the addition of clotrimazole to 
biopharmaceutical-producing hybridoma CRL 1606 cultures has a negative physiological 
impact in terms of apoptotic cell death and decreased glucose consumption. The 
quantification of the kinetics of induced hexokinase detachment from the mitochondria 
by clotrimazole, the changes in viability over longs times and assessment of apoptotic 
morphology, and the quantification of effects on glucose uptake rate are all novel 
contributions of this work. Furthermore, the metabolic and death effects of mitochondrial 
hexokinase detachment by clotrimazole in a biopharmaceutical-producing cell line have 
not been measured until now. The data from this study supports Aims I and II of this 
research: the effects clotrimazole on short-term glucose consumption and cell death have 
been quantified and the action of hexokinase re-localization to the cytosol by 
clotrimazole treatment has been verified. Below, I elaborate on the results and the 
potential implications that the data impart concerning the effects of clotrimazole 
treatment and mitochondrial hexokinase on both glucose consumption and cell survival. 
Clotrimazole treatment decreases the in vitro amount of hexokinase activity 
associated with the mitochondrial fraction (Figures 3.1 and 3.2). The amount of bound 
hexokinase never reaches zero, even for the highest tested clotrimazole concentration. 
This result corroborates previously published studies, which shows a “leveling off” of 
HK detachment between 15 and 40 µM, then a continuation of the decreasing trend.2 
Three potential explanations for this result are offered here. First of all, lack of complete 
detachment could be explained by the action of the molecule. Clotrimazole detaches 
mitochondrial hexokinase by inhibiting calcium transport across the mitochondrial 
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membrane. However, this is probably not a complete inhibition—some transport 
probably remains. Relatively little is known about the role of calcium in mitochondrial 
hexokinase binding, but it has been said to only “enhance” binding.15 Thus, even if there 
is absolutely no calcium transport (i.e., there is complete inhibition by clotrimazole), 
some basal level of hexokinase could still remain bound. Secondly, experimental error 
could potentially be to blame for the lack of complete detachment. If there is not a 
complete separation of the mitochondrial and cytosolic fractions, then ultimately we will 
never see all hexokinase in the cytosolic fraction since there will always be some 
contamination of HK in the mitochondrial fraction. However, there is no solid reason to 
believe this is occurring, particularly since the method has been proven to yield highly 
efficient separations and the lack of complete detachment corroborates previously 
published studies. And lastly, the fact that we do not see the mitochondrial HK activity 
reach zero could simply be due to investigating concentrations that are lower than 
required for complete detachment. 
In terms of the kinetics of hexokinase detachment via clotrimazole treatment, the 
action of the compound appears to be very rapid and reach saturation. This evidenced by 
the significantly decreased fraction of bound hexokinase at the initial time point for all 
treated cultures and a relatively constant value of fraction bound 1 and 2 hours after 
exposure for the higher clotrimazole concentrations. This mechanism of hexokinase 
detachment by clotrimazole is not well described—the compound is known to be a 
calmodulin antagonist, which among a few actions, is a protein known to bind calcium 
ions and maintain intracellular calcium transport. Disruption of this calcium transport 
across the mitochondrial membrane is thought to detach hexokinase.2 If clotrimazole 
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indeed has this effect in biopharmaceutical-producing cell lines, such as the hybridoma 
used here, then this suggests that calcium homeostasis is critical to cell survival.    
The data provide strong indications that clotrimazole-induced hexokinase 
detachment precedes cell death since 2 hours after exposure, viabilities of the 
clotrimazole-treated cultures were comparable to the control (Figure 3.5), yet each 
culture had lesser amounts of mitochondrial hexokinase e.g. fraction of hexokinase bound 
to the mitochondria at 1 hour (Figures 3.1 and 3.2). The data suggest that the decrease in 
amount of mitochondrial hexokinase bound in response to clotrimazole is an effect that 
occurs within about an hour time scale, as opposed to 10’s of hours and, more 
importantly, at a timescale that is faster than that observed for changes in metabolism, 
growth, and death in batch culture systems. The data also suggest that complete 
hexokinase detachment is not needed to induce cell death. At the higher clotrimazole 
concentrations (15 and 20 µM), the fraction of hexokinase bound to the mitochondria was 
about 10% 2 hours after exposure, yet apoptotic cell death presumably began occurring as 
early as four hours after exposure. Also, a relatively high viability is observed for the 
cultures receiving 2 µM clotrimazole even up to 16 hours after exposure despite 
seemingly having a larger fraction of unbound VDAC sites as compared to the control. 
Perhaps there is a certain percentage of VDAC sites that must be open to induce 
apoptotic death. Or if mitochondrial hexokinase is not mitigating cell survival in this 
case, then this suggests that calcium transport can be interrupted to a certain extent 
without inducing cell death.   
The fact that we see clotrimazole inducing death that exhibits apoptotic 
morphology is a significant finding. Does this mean that hexokinase detachment causes 
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apoptosis? This is a distinct possibility, although it must be conceded that clotrimazole 
may induce other intracellular events that cause apoptosis. The mechanistic action of 
clotrimazole as a specific calmodulin inhibitor allows these studies to identify targets 
which are important for cell survival and potentially glycolysis in this cell line. In 
addition to intracellular calcium homeostasis, calmodulin has been identified to be 
involved with the regulation a number of proteins, including cyclic nucleotide-dependent 
phosphodiesterase, nitric oxide synthase, calcineurin, and many kinases.19 Thus, since it 
is obvious that clotrimazole is detrimental to cell survival, then all the aforementioned 
proteins are targets that may be critical to cell survival for this hybridoma cell line.  
 Results from the metabolic rate screen reveal that clotrimazole causes less than a 
20% average decrease in glucose consumption over a 4-hour period, and the change in 
glucose consumption did not correlate with clotrimazole concentration in the 8-16 µM 
range. Whether or not the detachment of hexokinase by clotrimazole is the exact cause of 
the measured decrease in glucose consumption is not entirely clear, although it can 
certainly be said that cultures treated with clotrimazole are known to exhibit both 
decreased mitochondrial hexokinase activity and decreased glucose consumption in the 
hours prior to death. The most likely explanation for the observed dose-independent 
decrease in glucose consumption rate is the apparent dose-independency of mitochondrial 
hexokinase detachment by clotrimazole treatment over a similar concentration range. 
From Figure 3.2, we can see that the 10 and 15 µM concentrations, which most closely 
match the concentration range for the MRS experiments, do not exhibit statistically 
different amounts of mitochondrial hexokinase activity during the 2-hour exposure 
period. Thus, if 8-16 µM clotrimazole causes similar decreases in mitochondrial 
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hexokinase detachment, then a dose-independent decrease in glucose consumption rate 
over the same concentration range would be a plausible result. Secondly, it can be 
considered that hexokinase re-location to the cytosol may result in a rapid decrease in 
glucose consumption, but metabolic control dictates a quick return to a hypothetical 
setpoint based on current cellular energy demands by increasing the intracellular 
metabolite pool. This would certainly explain the similar average glucose uptake rates for 
each clotrimazole concentration over the 4-hour time period. And lastly, based on the 
varying effects of calmodulin inhibition, it must be considered that something other than 
clotrimazole-induced hexokinase detachment may have caused the 12-22% decrease, 
although it is impossible to know exactly what protein target would have been 
responsible for decreased glucose consumption and cell death. 
 Despite 8-16 µM clotrimazole causing dose-independent decreases in 
mitochondrial hexokinase activity and short-term glucose consumption, it should be 
noted that the 10 and 15 µM concentrations used in the AO/EB viability measurements 
(Figure 3.5) caused dose-dependent decreases in culture viability in the 4-hour and 8-
hour exposure times. Thus, the same amount of mitochondrial hexokinase detachment by 
clotrimazole leads to different amounts of cell death at later times, suggesting that 
something other than mitochondrial hexokinase detachment is controlling the cell death 
response.    
In summary, the clotrimazole treatment of CRL 1606 does have negative 
consequences for culture viability and reduces glucose consumption. Furthermore, 
decreases in mitochondrial hexokinase activity by clotrimazole treatment precede or 
coincide with these physiological changes. Clotrimazole treatment resulted in a dose-
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dependent decrease in viability, while the decrease in glucose consumption and 
mitochondrial hexokinase acitivity was dose-independent. The data imply that 
hexokinase detachment and reduced glucose consumption both occur prior to the visible 
occurrence of cell death (from the dye-based methods used in this study). The true in 
vitro metabolic significance of mitochondrial hexokinase needs further investigation in 
terms of studying a wider concentration range and dynamic metabolic responses rather 
than average rates over a specified time interval. The implications of clotrimazole 
toxicity (presumably by interrupting calcium homeostasis) and quantification of a 
detectable decrease in average glucose consumption for a biopharmaceutical-producing 
cell line extend far beyond hexokinase detachment from the mitochondria, although this 
event was the primary focus of Aims I and II of this research project. The overall result 
from this work is that the event of reduced mitochondrial hexokinase activity does 
precede cell death and coincides with decreased glucose consumption, which is very 
significant evidence to implicate a regulatory role for mitochondrial hexokinase in 
metabolic and apoptotic pathways in this hybridoma cell line.       
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CHAPTER IV 
 
ANALYSIS OF HEXOKINASE DETACHMENT IN BATCH  
HYBRIDOMA CULTURES 
 
Introduction 
The measurement of hexokinase activity in the cellular sub-fractions during batch 
hybridoma cell cultures has not been quantified, although a few studies have investigated 
total hexokinase activity in batch cultures. A 1993 study proposed that the decrease in 
hexokinase activity at late stage batch culture may be responsible for the low utilization 
of glucose at the end of the batch.1 This study included enzymatic measurements of 
hexokinase activity at 2, 4, and 7 days after subculture and found that by 48 hours, total 
hexokinase activity was decreased about 40%. However, no statistical significance was 
established for the measurements. Various articles discuss the activity of hexokinase, 
both total and in the sub-fractions, in mammalian cell types collected at various stages of 
culture, but not over time (Table 4.1). Clearly, quite a large range of the fraction of total 
hexokinase bound to the mitochondria has been determined based on the cell type 
studied.  
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Table 4.1. Published Values of Fraction of Hexokinase Bound to the Mitochondria 
for Varying Cell Types. All studies used cellular fractionation followed by enzymatic 
assay to determine the hexokinase activity in each fraction (mitochondrial and cytosolic).   
 
cell type mHK/tHK reference 
tumor 0.50 Parry, et. al., 19832, 3 
kidney 0.80 Parry, et. al., 19843 
hepatoma 0.78 Nakashima, et. al., 19864, 5 
hybridoma 0.25 Widjojoatmodjo, et. al., 19905 
NIH-3T3 0.40 Fanciulli, et. al., 19946 
myeloma 0.20 Vriezen, et. al., 19987 
 
 
Data and statistical analyses in Chapter II illustrated a phenomenon of decreasing 
glucose metabolism prior to cell death in batch hybridoma cultures. The specific cause of 
this decline is unclear, as is the particular apoptotic pathway responsible for instigating 
cell death. The results in Chapter III suggest that the biopharmaceutical-producing 
hybridoma cell line used in this study is sensitive to the Bax-induced apoptotic pathway, 
although it is not known if this pathway is involved in the natural apoptotic death that 
occurs in batch culture.    
The prospect of having variable amounts of hexokinase bound to mitochondria 
during batch culture make such a phenomenon a logical one to study given its prominent 
role both glycolysis and a major apoptotic pathway. Mitochondrially bound hexokinase 
presumably has preferential access to ATP, which may stimulate glycolysis.8, 9 Thus, 
discovery of a systematic detachment of hexokinase from the mitochondria during batch 
culture may certainly explain the steady decrease in glycolysis and would also provide 
insight as to the particular pathway responsible for apoptosis.  
In the Aim III phase of this project, hexokinase activities in the mitochondrial and 
cytosolic fractions were measured during high-viability hybridoma cultures. These 
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cultures were grown in the same manner as the cultures in Chapter II, and they 
presumably exhibit the same decreasing glucose consumption profile prior to apoptotic 
cell death. Preliminarily, models (based on Michaelis-Menten kinetics) to estimate the 
decrease in the fraction of hexokinase bound to the mitochondria and potentially the 
decrease in total hexokinase were developed. The experimental studies were performed in 
both T-flasks and spinner flasks. The experimental data and model estimates were 
compared. The data are used to discuss the potential roles of mitochondrial and cytosolic 
hexokinase in cell survival and mediation of glucose consumption in batch hybridoma 
cultures.       
 
Materials and Methods 
 
Cell Line and Maintenance 
The cell line used was a murine hybridoma (ATCC CRL-1606) that secretes an 
IgG against human fibronectin. During maintenance and all experiments, the hybridomas 
were cultivated in a serum-free, hydrolysate-free IMDM formulation, comprised of 
glutamine-free basal Iscove’s Modified Dulbecco’s Medium (IMDM, Mediatech) and 
supplemented with 4.0 mM glutamine (Mediatech), 10 mg/L insulin (Sigma), 5 mg/L 
holo-transferrin (Sigma), 2.44 µL/L 2-aminoethanol (Sigma), 3.5 µL/L 2-
mercaptoethanol (Sigma), and 10 U/ml penicillin – 10 µg/ml streptomycin (Mediatech). 
The hybridomas were cultivated in T-flasks (Corning) and maintained in an incubator 
(Forma Scientific) at 37°C, 10% CO2 and 95% humidity during maintenance.  
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Analytical Techniques 
 
Cell Counting and Apoptosis Determination 
Cell number and viability were determined via trypan blue dye exclusion using a 
hemocytometer. The viability was calculated as the number of viable cells divided by the 
number of total cells. A minimum of 2 slides were counted for each sample. Apoptotic 
morphology by the presence of DNA fragmentation was characterized using the acridine 
orange/ethidium bromide fluorescence assay.10 A total of 400 cells were counted for each 
slide for the determination of apoptosis. The percentage of each type of cell, whether it 
was deemed to be early apoptotic, late apoptotic, necrotic, or viable, was determined by 
dividing the number of each type of cell by the total number of cells counted. 
Differentiation of each cell type was determined by the visual inspection of fragmented 
DNA and color.  
 
Cell Fractionation and Hexokinase Activity Assay 
 The mitochondrial and cytosolic fractions were separated by the exact method 
described in Chapter III. Fractionated samples were stored at -80°C for later hexokinase 
activity analysis. Hexokinase activity in the mitochondrial and cytosolic fractions was 
determined by the exact method also described in Chapter III.  
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Batch Cultures 
 Batch experiments were performed either in T-flasks (Corning) or spinner flasks 
(Bellco Biotechnology) with an initial seeding density of 2.0 x 105 vcells/mL. After the 
initial seeding, the cultures were counted using trypan blue dye exclusion method and 
incubated at 37°C, 10% CO2, and 95% humidity in an incubator. At specific time points 
during the early and late stages of each culture, the cultures were counted again by trypan 
blue due exclusion (2 slides), and a total of 1e7 cells was sampled into a centrifuge tube. 
The sample was centrifuged at 200g for 15 minutes (Forma Scientific Centrifuge) to 
pellet the cells. The mitochondrial and cytosolic fractions in this sample were 
fractionated in a sucrose buffer and stored at -20°C for later hexokinase activity analysis. 
The speed of the impeller in the spinner flask studies was set to approximately 60 RPM. 
Cell death exhibiting apoptotic morphology was verified in the spinner flask studies by 
AO/EB counting after the viability dropped below 50%.      
 
Preliminary Modeling 
 
Model I: Estimation of Hexokinase Detachment from the Mitochondria in Batch Cultures 
 Prior to experimentation, I developed a model to estimate the expected decrease 
in the fraction of hexokinase bound to the mitochondria in batch cultures based on the 
measured profile of glucose concentration in batch cultures. This model was based on the 
following primary assumptions: (1) the total concentration of hexokinase does not change 
over time, (2) initially (just after subculture), 25% of the total amount of hexokinase is 
bound (estimate from Table 4.1), (3) mitochondrial and cytosolic hexokinase possess 
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different kinetic properties (i.e., k and Km values)11, 12, (4) the detachment is described by 
non-reversible, first order kinetics, and (5) the rate of glucose consumption is equal to the 
rate of glucose phosphorylation to glucose-6-phosphate. First, I assumed a first-order rate 
of detachment for mitochondrial hexokinase (equation 4-1).  
 cHK
k
mHK CC →          (4-1) 
For the purposes of this model, both mitochondrial and cytosolic hexokinase 
concentrations are expressed on a per volume of cytosol basis (mmol/Lcytosol). Writing the 
rate law, we get 
mHK
cHKmHK kC
dt
dC
dt
dC −=−=        (4-2)  
where CmHK is the concentration of mitochondrial hexokinase, CcHK is the concentration 
of cytosolic hexokinase, and k (hr-1) is the first-order rate constant. Assuming the rate of 
detachment is constant, equation 4-2 can be integrated to yield equation 4-3, 
 ktmomHK eCC −=         (4-3) 
where Cmo (mmol/Lcytosol) is the initial concentration of mitochondrial hexokinase. 
Assuming that the total mass of hexokinase remains constant, the concentration of 
cytosolic hexokinase is equal to the sum of the initial concentration and the change in the 
concentration of mitochondrial hexokinase,  
kt
momococHK eCCCC
−−+=        (4-4) 
where Cco (mmol/Lcytosol) is the initial concentration of cytosolic hexokinase. The 
conversion of intracellular glucose to glucose-6-phosphate can be assumed to be modeled 
by Michaelis-Menten enzyme kinetics. Since the intracellular pool of glucose is very 
low,13 we can use the simplified form for low substrate concentration (equation 4-5),14 
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m
glcmaxglc
K
CV
dt
dC −=         (4-5) 
where Cglc (mmol/Lcytosol) is the intracellular glucose concentration, Vmax 
(mmol/Lcytosol/hr) is the maximal rate of reaction, and Km (mmol/Lcytosol) is the Michaelis-
Menten constant. However, we do know that Vmax is equal to a reaction rate k times the 
enzyme concentration. Assuming that both mitochondrial and cytosolic hexokinase have 
different k and Km values, we can write an expression for the overall rate of glucose 
phosphorylation,  


 +=
cm
cHK2
mm
mHK1
glc
glc
K
Ck
K
Ck
C
dt
dC
       (4-6) 
where k1 and k2 (hr-1) are the reaction rate constants for product formation for 
mitochondrial and cytosolic hexokinase, respectively, and Kmm and Kcm (mmol/Lcytosol) 
are the Michaelis constants for mitochondrial and cytosolic hexokinase, respectively. We 
also know from the literature (and from my own data) that during mid-exponential phase 
hybridoma cultures, the fraction of total hexokinase bound to the mitochondria is around 
0.20-0.25.5 Thus, 
  25.0
CC
C
como
mo =+         (4-7) 
Substituting 4-3, 4-4, and 4-7 into 4-6, we get 



 −+=
−−
cm
kt
mo2
mm
kt
mo1
glc
glc
K
)e4(Ck
K
eCkC
dt
dC
     (4-8) 
Equation 4-8 was rearranged and integrated from Cglco (initial glucose concentration) to 
Cglc and 0 to t to yield the model, 
CBtAe)Cln( ktglc ++= −        (4-9) 
where A, B, and C are described by equations 4-10 through 4-12. 
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K
Ck
K
Ck
A cm
mo2
mm
mo1
−
+
=        (4-10) 
cm
mo2
K
Ck4B =          (4-11) 
)Cln(
k
K
Ck
K
Ck
C glcocm
mo2
mm
mo1
+
−
=       (4-12) 
The outcome of this model is to calculate k, the average rate of detachment, and estimate 
the ratio of the amount of mitochondrial hexokinase to the total amount of hexokinase. 
Furthermore, the estimates of A, B, and C yield an insight as to how much more efficient 
mitochondrial hexokinase must be as compared to cytosolic hexokinase.  
 The model was performed using the known glucose concentration profiles from 
Chapter II, which were converted to mmol/L of cytosol using an estimated cell volume 
(Vcell~1375 µm3)15 and the viable cell density, which was measured. The model fitting 
was performed using MatLab and the LSQNONLIN non-linear curve fitting function. 
The unknowns, A, B, C, and k, were the output parameters of the program. The fraction 
of hexokinase bound was estimated by equation 4-13 (using 4-3 and 4-4). 
kt
cHKmHK
mHK e25.0
CC
C
tHK
mtHK −=+=        (4-13) 
 
Model II: Estimation of Changes in Total Hexokinase Activity 
 It is possible that the intracellular location of hexokinase has no effect on its 
activity. If this is the case, then the decrease in glucose uptake may possibly be explained 
by an overall decrease in the total amount of hexokinase. To estimate the relative 
decrease in the total amount of hexokinase that would contribute to the observed decrease 
in glucose consumption, I simplified the above model (equation 4-6) to equation 4-14, 
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m
glctHKglc
K
CCk
dt
dC ′=         (4-14) 
where CtHK (mmol/Lcyotsol) is the total concentration of hexokinase, k′ (hr-1) is the rate 
constant for product formation from the hexokinase-glucose complex, and Km 
(mmol/Lcytosol) is the Michaelis constant. Rearranging, we have 
glc
mglc
tHK C
K
*
dt
dC
Ck =′         (4-15) 
The left hand side of equation 4-15 is equal to the activity of the enzyme. Since glucose 
concentration as a function of time is known, it can be converted to a per cell basis using 
the viable cell density. The Km value was estimated to be 0.1 mM.16   
 
Error Analysis and Statistical Methods 
Statistical comparisons for the fraction of hexokinase bound to the mitochondria 
and total hexokinase between 20 and 48 hours for the T-flask measurements was 
performed by the student’s t-test. The errors on the measurements for these experiments 
were calculated as the standard deviation of 6 replicates.   
A statistical comparison among the time points in which hexokinase activity was 
measured in the spinner flasks was performed using a Model I ANOVA. If statistical 
significance was established by calculating an F value greater than the critical F at the 
specified degrees of freedom, the ANOVA was followed-up with Tukey’s Test, which 
compares the differences in means for each pair to a least significant difference. If the 
difference in means for a pair is greater than the least significant difference, then there is 
a statistically significant difference. The errors on each measurement for the spinner flask 
experiments were calculated as the standard deviation of the 3 independent replicates.     
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Results 
 
Preliminary Model Estimates 
Prior to measuring the hexokinase activity in the mitochondrial and cytosolic 
fractions in batch cultures, I formulated two models to estimate (1) the observable 
decrease in the fraction of hexokinase bound to the mitochondria that would be 
necessary to produce the calculated decrease in glucose uptake during batch cultures and 
(2) the observable decrease in the total hexokinase activity that would be necessary to 
produce the calculated decrease in glucose consumption during batch cultures assuming 
that hexokinase does not possess varying kinetic properties by virtue of its intracellular 
location. The glucose concentration curves from the four batch experiments in Chapter II 
were used for these models. I should note here that glucose concentration profiles were 
not determined for the batch experiments used to measure hexokinase activity in this 
chapter.   
Based on the first model, the output of which is an estimate for first-order rate of 
detachment (k) of mitochondrial hexokinase, the fraction of total hexokinase bound 
would have to decrease from about 0.18 to 0.12 between the early and late stages of 
culture for T-flask cultures and 0.19 to 0.13 for spinner flask cultures (Table 4.2). This 
represents slightly over a 30% decrease for both modes of cultivation. The model 
estimated an average k value (first-order rate of detachment) of 0.015 hr-1. This number is 
the average from all four flasks.  
The second model is a variation on the first, and estimates the decrease in total 
hexokinase activity over time that would be necessary for the commensurate decrease in 
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glucose consumption. According to the model, the expected decrease in total hexokinase 
activity for T-flask cultures is about 60%, although the spinner flask models only 
estimate about a 23% reduction in total hexokinase activity between 20 and 48 hours. The 
variability of the model estimates is due to inoculum variations of the batch experiments 
(i.e., differing glucose concentration profiles). It should also be noted that the magnitude 
of the total hexokinase activity/cell is not the same as the experimental measurements 
since the models were carried out using estimates for Michaelis-Menten constants as well 
as cell volume. Hence, only the relative decrease over time is of interest, not the absolute 
magnitude.       
 
Table 4.2. Model Predictions for the Fraction of Hexokinase Bound to the 
Mitochondria (Model I) and Total Hexokinase Activity (Model II) in Batch CRL 
1606 Cultures Cultivated in T-Flasks and Spinner Flasks. Data show the results of 
both models. Error bars represent the standard deviation of the two spinner flask 
experiments. * x10-11 
 
 
Time 
(hours) 
Model I 
mHK/tHK 
Model II 
total hexokinase 
(units/cell)* 
 T-Flasks 
20 0.18±0.04 4.3±1.3 
48 0.12±0.06 1.7±0.1 
 Spinner Flasks 
8 0.22±0.002 3.0±0.6 
20 0.19±0.004 3.5±0.3 
32 0.16±0.005 2.7±0.2 
40 0.14±0.005 2.4±0.04 
48 0.13±0.006 2.7±0.4 
 
 
 
 Thus, based on these models, cultures grown in both T-flasks and spinner flasks 
should exhibit an approximately 30% reduction in the fraction of hexokinase bound to the 
mitochondria, respectively, between 20 and 48 hours after subculture. Next, experiments 
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are performed to measure the fraction of hexokinase bound over the course of batch 
cultures and compare the model estimates.   
 
T-Flask Cultivation Studies 
 The first experimental part of this study investigated the differences in the fraction 
of hexokinase bound to the mitochondria for cells cultivated in T-flasks. Only 2 time 
points were measured: 20 hours and 48 hours after subculture. This is the minimal 
amount of data needed to make a claim that hexokinase detaches from the mitochondria 
over time in batch cultures, and also the relatively small culture volume of a T-flask 
limited the number of sampling times. Figure 4.1 illustrates the fraction of total 
hexokinase bound to the mitochondria and the total hexokinase activity per cell at 20 and 
48 hours after subculture for hybridomas cultivated in T-flasks. These time points were 
chosen to coincide with (1) the approximate time of peak metabolism and (2) the 
metabolism just prior to visible apoptotic cell death. The data represent 6 replicates. The 
first observation that can be made from this data is that less than 25% of the total amount 
of hexokinase appears to be bound to the mitochondria, even at the early stages of 
culture. Secondly, there does appear to be a 17% reduction in the fraction of hexokinase 
bound to the mitochondria, though this is lower than expected from the model estimates. 
Furthermore, the total amount of hexokinase appears to remain constant, although no 
time points were measured between 20 and 48 hours. The average growth rate for these 
cultures between 20 and 48 hours was 0.045±0.003 hr-1, similar to the T24 flask in 
Chapter II which exhibited an average growth rate of 0.043 hr-1 during the same time 
period.       
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Figure 4.1. Fraction of Hexokinase Bound to the Mitochondria and Total 
Hexokinase Activity at 20 and 48 Hours after Subculture for CRL 1606 Cultures 
Cultivated in T-Flasks. Less than 25% of the total hexokinase is bound 20 hours after 
subculture (black bars). There is statistical evidence of decreased mitochondrial 
hexokinase association between 20 and 48 hours after subculture, but the decrease 
appears to be fairly slight (~17% decrease). Statistical treatment via the student’s t-test 
showed statistical difference at the 95% confidence level. There is no statistical evidence 
of a decrease in total hexokinase activity between 20 and 48 hours (grey bars). Error bars 
represent the standard deviation of 6 replicates. *p<0.05.  
 
 
It is clear from the T-flask data that more time points are needed for a thorough 
analysis of the changes in hexokinase distribution in batch cultures. This could only be 
accomplished by performing measurements in a spinner flask due to the large sample size 
(1e7 total cells) required for the fractionation procedure and the hexokinase activity 
assay. Thus, I amended the experimental protocol to cultivations in spinner flasks and 
increased sampling times.  
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Spinner Flask Cultivation Studies 
 The data set for detachment of hexokinase from mitochondria in batch culture was 
next expanded by using the same experimental procedure, but with an increased number 
of time points and an alternate cultivation method. Spinner flasks were used in this study 
because they hold much larger culture volumes as compared to T-flasks, which allows for 
a greater number of measurements to be made. As we can see from Figure 4.2A, a sort of 
equilibrium between mitochondrial and cytosolic hexokinase is maintained throughout 
the batch cultures given the fact that the fraction of total hexokinase bound does not 
change. Application of a Model I ANOVA resulted in an insignificant F value, indicating 
that no pairs of time points are significantly different. The fraction of total cells which 
apoptotic morphology (DNA fragmentation) was over 75% at the late stages of cultures, 
as verified by AO/EB counting. The average growth rate for these cultures over the 20-48 
hour period was 0.054±0.004 hr-1, which is notably higher than the spinner flask cultures 
from Chapter II which exhibited an average growth rate of 0.040±0.004 hr-1 over the 
same time period.   
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Figure 4.2. The Ratio of Mitochondrial Hexokinase Activity to Total Hexokinase 
Activity and Total Hexokinase Activity in Batch CRL 1606 Cultures Cultivated in 
0.5 L Spinner Flasks. The fraction of hexokinase bound to the mitochondria remains 
static over the course of batch culture (A). However, the total hexokinase activity per cell 
exhibits a decreasing trend, although statistical significance could not be established (B). 
Error bars represent the standard deviation of 3 independent replicates.    
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 Even though the fraction of hexokinase bound to the mitochondrial appears to 
remain static, there is evidence that the total amount of hexokinase is decreasing over 
time in batch cultures (Figure 4.2B). Summing the measured activities in the 
mitochondrial and cytosolic fractions, there appears to be a 27% decrease in the total 
hexokinase activity. It should be noted that statistical comparisons were not significant in 
any case. In both the T-flask and spinner flask cultures, total mitochondrial hexokinase 
activity decreased ~22% between 20 and 48 hours.       
 
Comparison of Experimental Measurements to Model Estimates 
Using the model predictions and experimental data at 20 and 48 hours after 
subculture, comparisons can be made on the expected decrease in the fraction of 
hexokinase bound to the mitochondria and the total hexokinase activity. The comparisons 
are summarized in Table 4.3. The decrease in the fraction of hexokinase bound between 
20 and 48 hours after subculture is only about 17% for the T-flask cultures and there is a 
slight (yet insignificant) increase for the spinner flask cultures. These values are clearly 
lower than expected. The change in total hexokinase in the spinner flasks did correspond 
nicely to model estimates, however. The T-flasks exhibited almost no change in total 
hexokinase between early and late-stage culture.  
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Table 4.3. Comparison of Model Estimates and Experimental Data: Decrease in 
Total Hexokinase and Fraction of Hexokinase Bound to the Mitochondria between 
20 and 48 Hours after Subculture. The estimated decrease in total hexokinase is much 
greater for the T-flask cultures since these cultures exhibited a larger decrease in glucose 
metabolism over the 20-48 hour time interval.   
 
 T-Flasks Spinner Flasks 
 Total 
Hexokinase 
mHK/tHK Total 
Hexokinase 
mHK/tHK 
 
Model (Predicted) 
 
-58.6% -35.7% -22.1% -32.9% 
 
Experimental 
 
-5.2% -16.8% -27.0% +6.7% 
 
     
Discussion 
 The data presented in this chapter represent novel work on the investigation of 
changes in hexokinase association with the mitochondria in batch hybridoma cell 
cultures. There are three major findings from this Aim III study: 
 
• The fraction of hexokinase bound to the mitochondria for hybridoma cultures 
grown in a T-flask decreases an average of 17% between 20 and 48 hours after 
subculture, while spinner flask cultures exhibited no statistical change in the 
fraction bound over time. These measurements did not match model predictions. 
• No statistical change in total hexokinase activity is evident for cultures grown in 
T-flasks or spinner flasks. 
• Cultures grown in both T-flasks and spinner flasks exhibited a 22% decrease in 
total mitochondrial hexokinase activity (on a per cell basis) between 20 and 48 
hours after subculture, but the decrease was not statistically significant.  
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The T-flask cultures appear to exhibit a small decrease in the fraction of 
hexokinase bound to the mitochondria (~17%) between early and late stage culture, but 
the spinner flask cultures showed a consistent (and higher) ratio of mitochondrial to total 
hexokinase activity between 8 and 48 hours after subculture. This clearly suggests that 
there are some inoculum differences based on the mode of cultivation. Hybridomas 
cultivated in spinner flasks have different levels of dissolved oxygen, grow more quickly, 
and die more quickly than those cultivated in T-flasks. Perhaps coincidentally, the 
average growth rate for the spinner flask cultures between 20 and 48 hours was ~17% 
higher than the T-flask cultures. However, it is not clear if mitochondrial hexokinase is 
related to growth in any way. The effects of differing environments are clearly seen in the 
mitochondrial hexokinase activity. Higher growth rates in the spinner flask cultures imply 
higher rates of glycolysis and higher flux through the TCA cycle, and this could 
subsequently mean higher amounts of hexokinase bound to the mitochondria. If in fact 
the spinner flasks are more highly oxygenated due to constant stirring, then this would 
imply that higher levels of dissolved oxygen effect the fraction of hexokinase bound to 
the mitochondria. I did not measure dissolved oxygen levels, so it is not known if the 
spinner flasks really do provide higher levels of oxygenation. Thus, it is possible that the 
mitochondrial-mediated pathway (potentially activated by hexokinase dissociation) is 
more active when cultures are grown in T-flasks if there is in fact less dissolved oxygen 
available. However, further study would be needed to investigate this point and make a 
claim regarding its validity.       
In terms of total hexokinase activity and the activities in each separate fraction, 
the T-flasks exhibited no change in hexokinase activity between 20 and 48 hours, but the 
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spinner flask data does provide evidence that the total amount of hexokinase (both 
mitochondrial and cytosolic) is decreasing over time, although statistical significance 
could not be established. The profile corresponds to that of the assumed glucose 
consumption (i.e., peaks at ~16-20 hours after subculture and declines throughout the 
duration of the batch). This decrease does in fact correlate with model estimates, which 
predicted a 22% decrease in total hexokinase activity between early and late stages of 
culture, while the measurements illustrated about a 27% decrease between early and late 
stages of culture. However, I must claim here that total hexokinase activity is remaining 
constant throughout all batch cultures since no measurements were statistically different. 
More replicates would be needed to determine if a decrease in total hexokinase activity 
does in fact correspond to (and could potentially be the cause of) the decrease in glucose 
consumption rate.    
In comparison to the expected decreases in glucose consumption during these 
batch cultures, the hexokinase activity appears to change very little between 20 and 48 
hours. In Chapter II, the glucose consumption in the T-24 flask decreased about 62% 
between 20 and 48 hours, yet a similar culture in this Aim III study exhibited only a 17% 
decrease in the fraction of hexokinase bound to the mitochondria and no change in the 
total hexokinase activity. And the spinner flask cultures from Chapter II showed an 
almost 60% decrease in glucose consumption between 20 and 48 hours, yet there was no 
change at all in the fraction of hexokinase bound. Thus, the decrease in glucose 
consumption in the both spinner flask and T-flask cultures appears to occur despite nearly 
constant levels of total hexokinase activity. This suggests that something even more 
upstream than the hexokinase-catalyzed reaction is responsible for decreasing glucose 
 102
consumption, and the most probable target is the availability of glucose transporters on 
the cell membrane. A decreasing concentration of these transporter proteins would 
logically cause a decrease in glucose consumption.  
 These cultures die by apoptosis despite little or no change in mitochondrial 
hexokinase throughout the high-viability period. The implication of these results is that 
mitochondrial hexokinase is not critical during high-viability batch hybridoma cultures. 
However, I must concede that the pathway may still be active and may even be the 
predominate death pathway since systematic detachment may occur immediately before 
the onset of death. But in the hours leading up to death, there is apparently no change in 
mitochondrial hexokinase. Perhaps the hypothesis that changes in cellular physiology that 
occur during high-viability periods of culture may contribute to later apoptotic cell death 
is not a valid one, although some environmental, genetic, and/or molecular factor must be 
instigating cell death, either at early or late stage culture. And other apoptotic pathways 
do exist that are potentially active and may cause death in batch hybridoma cultures. 
These will be outlined in more detail in Chapter V.     
Perhaps the role of mitochondrial hexokinase in cell survival is much stronger 
than its role in metabolic regulation. This is evidenced in both the Aim I and III studies. 
In the metabolic rate screening experiments with clotrimazole, we observe the same 
average glucose consumption despite differing levels of mitochondrial hexokinase. And 
in the Aim III studies, we observe differing amounts of glucose consumption during 
batch cultures despite no changes in mitochondrial hexokinase activity. So clearly, 
mitochondrial hexokinase is exerting little metabolic regulation in vitro. And despite the 
effects of clotrimazole on calcium homeostasis and perhaps intracellular kinases, we do 
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see that hexokinase in becoming detached from the mitochondria before apoptotic cell 
death. So, these are clear reasons to believe that mitochondrial hexokinase has a stronger 
role in protection from apoptotic cell death rather than glycolytic control.   
From this study, targeting increased mitochondrial hexokinase does still appear to 
be a viable option for delaying cell death in biopharmaceutical-producing cell lines 
despite the fact that we observe only minor changes or no change at all in the fraction 
bound over time in batch cultures. Presumably due to culture heterogeneity, a 
subpopulation is dying via this pathway, and ensuring that all VDAC sites are occupied 
would delay death in that particular subpopulation. Cells complete apoptosis at different 
rates and probably by different pathways. Learning why some cells die and other live 
much longer is critical in optimizing cultures for bioprocesses. Here, mitochondrial 
hexokinase appears to be playing no role in physiological changes during high-viability 
cultures, but this pathway could quickly become active just prior to cell death.   
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CHAPTER V 
 
DISCUSSION OF EXPERIMENTAL FINDINGS AND CONCLUSIONS 
 
Summary and Discussion of Key Findings 
 Table 5.1 summarizes the key findings of this research project. Generally, the 
fraction of hexokinase bound to the mitochondria was not found to decrease over time in 
batch hybridoma CRL 1606 cultures. Thus, the evidence collected in this research project 
does not provide support for the Aim III hypothesis. The data from Aim III of this project 
do provide some indication that both total hexokinase and mitochondrial hexokinase 
activity are decreasing in batch hybridoma cultures, but no statistical differences could be 
established. The cause(s) of the decline in glucose consumption quantified in Chapter II 
and the specific pathway responsible for apoptotic death in CRL 1606 still lack clear 
explanation, but the results of this project eliminate one possible molecular event that 
may contribute to both decreasing metabolism and death during high-viability cultures. 
For hybridomas cultivated in spinner flasks, the decrease in total hexokinase activity is 
certainly commensurate with the decrease in glucose consumption, although I must claim 
that total hexokinase activity is remaining relatively constant throughout batch cultures in 
both T-flasks and spinner flasks since there were no statistical differences in the activity 
measurements. And even though the cells are susceptible to induced hexokinase 
detachment by clotrimazole, it cannot be concluded that the cells are naturally dying via 
this pathway in batch culture. Furthermore, although the event of induced hexokinase 
detachment by clotrimazole does precede cell death exhibiting apoptotic morphology and 
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coincides with a dose-independent decrease in glucose consumption, these changes in 
physiology cannot unquestionably be attributed to hexokinase detachment from the 
mitochondria.    
 
Table 5.1. Summary of Key Research Findings. The phase of the research project is 
listed to the left, and the major results of each phase are listed to the right.  
 
Project Phase Results 
Preliminary 
Studies 
• Glucose consumption rate decreases early (<24 hours after subculture) 
in batch culture (statistically). 
• Glucose consumption rate decreases statistically prior to decreases in 
growth rate and apoptotic cell death.  
 
Aim I 
 
 
• Clotrimazole treatment results in cell death exhibiting apoptotic 
morphology. 
• Clotrimazole treatment results in slightly reduced, dose-independent 
glucose consumption over a 4-hour exposure time. 
 
Aim II 
 
 
• Clotrimazole treatment of hybridoma cultures causes dose-dependent 
reduced mitochondrial hexokinase activity prior to cell death. 
Aim III • Hybridoma cultures grown in T-flasks exhibit ~17% decrease in the 
fraction of total hexokinase bound to the mitochondria between 20 and 
48 hours after subculture. 
• Hybridoma cultures grown in spinner flasks exhibit no change in the 
fraction of total hexokinase bound to the mitochondria between 8 and 48 
hours after subculture. 
• Both T-flask and spinner flask data do not show statistical evidence of 
decreasing total hexokinase activity during batch cultures. 
      
 
It is my premise that a systematic detachment is not occurring given the results 
and analysis of the measurements. There was some indication of a relatively slight 
decrease in the fraction of hexokinase bound between 20 and 48 hours after subculture in 
T-flask cultures, but hybridomas cultivated in spinner flasks showed absolutely no 
change in the fraction bound despite presumably declining glycolysis and meeting the 
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same apoptotic fate. And even though statistical difference could not be established, there 
remains evidence that mitochondrial hexokinase activity (not fraction bound) is 
decreasing during batch culture. Culture heterogeneity would dictate that perhaps a 
certain subpopulation of cells experiences this phenomenon of decreasing mitochondrial 
hexokinase activity, which would open VDAC sites and potentially result in apoptotic 
protein release, but I cannot say this is happening with any degree of certainty.   
With further study, a decrease in total hexokinase activity may explain decreasing 
glucose consumption in spinner flasks, but the T-flask cultures exhibited no change in the 
total activity, despite evidence of slight re-distribution between the mitochondrial and 
cytosolic fractions. This suggests that perhaps the cause of declining metabolism and the 
pathway to apoptotic cell death is dependent on external culture conditions, particularly 
since spinner flask cultures differ in the amount of oxygenation. I cannot say, however, 
that changes in hexokinase activity are responsible for declining glycolysis. If in fact 
changes in either mitochondrial hexokinase activity or total hexokinase activity have any 
effect on glucose consumption, it is most likely working in tandem with some other 
event. Perhaps there are changes in the expression of cell-surface glucose transporters? 
This is just one of many possibilities that could be causing, or at least contributing to, 
declining glycolysis.       
Mitochondrial hexokinase may not be controlling glycolysis per se, but the 
metabolic rate screening experiments of Chapter III do perhaps indicate that 
mitochondrial hexokinase may have some sort of influence over glucose consumption. A 
previous study showed dose-dependent decreases in glycolytic intermediates and ATP 
after 30 minutes of exposure to clotrimazole for carcinoma cells.1 The exposure times 
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used in my study were much longer in order to gain significant changes in extracellular 
glucose concentration for specific rate calculations. As stated in the Chapter III 
discussion, perhaps this longer exposure time allowed for the cells to respond 
metabolically to the change in hexokinase location. However, if the decrease in glucose 
consumption was not dependent on the extent of hexokinase re-localization, this strongly 
suggests that mitochondrial hexokinase did not mediate the effects on glycolysis in these 
experiments. The intracellular calcium disruption of clotrimazole is a more likely cause 
for this metabolic response, but no papers have quantified metabolism of hybridoma 
cultures in response to calcium disruption, so I cannot compare this result to any 
literature results.       
The results of Aims I and II do provide some indication that hexokinase 
detachment from the mitochondria does in fact induce apoptotic death, perhaps through 
the Bax-dependent pathway. Even though short-term glucose consumption was 
independent of clotrimazole concentration, cell viability over long times (up to 16 hours 
after exposure) was clearly dose-dependent. This fact suggests that death pathways can 
activate and execute the apoptotic mechanism with little or no influence on cellular 
metabolism. If hexokinase detachment from the mitochondria does in fact open VDAC 
sites and cause mitochondrial permeability, then it would logically follow that ATP 
production would be reduced, which would decrease overall glycolysis while potentially 
increasing glucose consumption (since the cells would presumably be energy starved). 
Hexokinase detachment by clotrimazole is clearly observed, but with little effect on 
glucose consumption. This could possibly mean that hexokinase binding does not affect 
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mitochondrial permeability, although further research must be performed to investigate 
this point.    
 Given the data in this research project, it is clear that an even more specific study 
is needed to more comprehensively understand the changes in mitochondrial physiology 
and hexokinase location during batch culture. Although the cell-free studies with isolated 
mitochondria cited in Chapter I indicate that mitochondrial hexokinase is needed to 
maintain mitochondrial integrity and prevent apoptotic protein release, we have little in 
vitro evidence of this. Are the mitochondria becoming permeable during batch culture? 
This is not known. Very few studies have employed the experimental methodology of 
measuring physiological or molecular phenomenon over time in batch culture. Although 
the location of hexokinase seems critical to cell survival and glycolysis, there is little or 
no evidence of a re-distribution during the high-viability phase of batch culture and, 
perhaps most importantly, in the hours just prior to apoptotic cell death.       
 
Mitochondrial-Mediated Apoptotic Pathway in Batch Hybridoma  
Cultures: Active or Inactive? 
 
 Through the Aims I and II studies, we can see that the hybridoma cell line is 
certainly susceptible to induction of the mitochondrial-mediated apoptotic pathway, 
although there is little evidence to suggest that this pathway is responsible for the natural 
occurrence of apoptosis in batch culture. There are three predominate apoptotic pathways 
in which the cells can die: (i) mitochondrial-mediated, (ii) receptor-mediated, and (iii) 
endoplasmic reticulum (ER) stress-mediated.2 The mitochondria are involved to some 
extent in all these pathways, so the mechanisms of hexokinase detachment may or may 
not be part of all three. Furthermore, I do have preliminary evidence of caspase-3 activity 
 111
in later stage batch cultures, although this data was not included as part of the project 
results since the interpretation carries a high level of uncertainty.  
An assumption of this research project is that the mitochondrial-mediated 
pathway is the dominate mode of death in batch cultures, but the project results cast some 
doubt on that assumption. The fact that caspase-3 is active in later stages of cultures does 
not necessarily imply mitochondrial-mediated apoptosis since caspase-3 is a late 
apoptotic marker involved in all three pathways. However, even this research and 
previous studies still point to the mitochondrial-mediated pathway as the most likely 
pathway to apoptotic death considering that inhibition of signaling molecules or growth 
factors that are known to directly affect mitochondrial function induce apoptosis.3, 4 But 
again, just because a pathway is identified as active through induction does not mean that 
this is the natural mode of death in batch cultures. Clearly, literature studies are lacking in 
identifying the known mechanisms of apoptosis in batch mammalian cell culture.  
Table 5.2 summarizes the research into methods that are known to either delay or 
induce apoptotic cell death in hybridoma cultures. What can be gleaned from this 
conglomeration of research? It’s quite difficult to say since there are clearly a host of 
targets which affect cell death in hybridoma cultures. Research in this area appears rather 
fragmented, meaning there’s no clear trend as to the elucidation of active pathways in 
hybridoma cultures. But most notably, methodologies that affect mitochondrial 
physiology do exert death effects. This leads me to believe that the effects of clotrimazole 
on mitochondrial physiology, and more specifically the detachment of hexokinase, may 
also be the reason that death is induced. And I cannot be completely certain that 
mitochondrial-mediated apoptosis though hexokinase detachment is not predominate in 
 112
batch cultures simply because I analyzed changes during high-viability cultures only. I 
can only be certain that this pathway is not becoming active in the hours prior to the onset 
of cell death and not contributing to declining glucose consumption.        
 
Table 5.2. Summary of Research into Apoptotic/Metabolic/Signaling Pathways and 
the Effects on Death in Hybridoma Cultures. This table summarizes environmental 
and genetic targets known to effect cell survival in hybridoma cultures.     
 
Research Death  
Effects 
Intracellular 
Target 
Reference 
bcl-2 over-expression 
 
delayed mitochondrial 
permeability 
Chung, 19985 
Itoh, 19956 
 
rapamycin  
 
delayed mTOR Balcarcel, 20017 
z-VAD-fmk  
 
delayed caspase inhibition Tinto, 20028 
LY294002  
 
induced Akt/PKB inhibition 
 
Clark, Thesis, 2005 
amino acid/glucose/nutrient 
feeding 
 
delayed metabolic fluxes Xie 19949 
rotenone  
 
induced mitochondrial 
electron transport 
 
Follstad, 200010 
staurosporin induced calcium-dependent 
protein kinase 
 
Follstad, 200010 
high MMP subpopulation 
selection 
 
delayed mitochondrial 
permeability 
Follstad, 200010 
clotrimazole  
 
 
induced intracellular calcium; 
mitochondrial HK 
Clark Thesis, 2005 
    
 
Effects of Clotrimazole on CRL 1606 and ER-Mediated Apoptosis 
In order to more comprehensively understand the implications of the measured 
effects of clotrimazole treatment and perturbation of the Bax-induced apoptotic pathway, 
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we must look at the exact action of clotrimazole. Clotrimazole might induce cell death 
through hexokinase detachment, but hexokinase detachment seemingly has little to do 
with natural apoptotic death in batch culture. However, clotrimazole presumably acts to 
detach hexokinase through disruption of calcium transport.11 If disruption of calcium 
transport is in fact the root cause of the apoptotic death and decreased glucose 
consumption quantified in Aims I and II, then what role does calcium play in cellular 
homeostasis? Clearly a very large role, if this is in fact the main effect of the compound. 
In fact, deprivation of extracellular calcium ions, which causes a commensurate depletion 
of intracellular calcium ions due to equilibrium,12 is known to induce apoptosis (by 
assessment of DNA laddering in gel electrophoresis) in hybridoma cell cultures, but over-
expression of bcl-2 suppresses this effect.13  
After further investigation into the function of intracellular calcium, I uncovered 
that it plays a role in the ER stress-induced apoptotic pathway.2 This pathway is known to 
be activated by calcium depletion in pancreatic β-cells.14 Thus, as an alternate hypothesis, 
clotrimazole could be inducing apoptotic death via the ER-stress mediated pathway as a 
result of interruption of calcium homeostasis. It doesn’t appear logical that bcl-2 over-
expression would counteract the apoptotic effects of calcium deprivation, but 
interestingly, bcl-2 protein not only binds mitochondria, but it also binds the endoplasmic 
reticulum in various cell types.15-17 This might very well explain why bcl-2 over-
expression successfully extends cell culture viability in hybridoma cultures—it not only 
binds mitochondria, but impedes ER-mediated stress pathways as well? And perhaps this 
is the dominate mode of death for hybridoma cultures. The fact that I witnessed caspase-3 
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activity in late stage cultures corroborates this hypothesis since caspase-3 is indeed part 
of the ER stress-mediated pathway.    
Future Research 
 Given the results of the project, future work can be performed to gain more 
knowledge on the role of mitochondrial hexokinase in cellular metabolism and cell 
survival. Clearly, another method of hexokinase detachment would be desirable—a 
method that does not present other possibilities for observed changes in cellular 
physiology other than hexokinase detachment. There are other compounds that are known 
to result in decreased mitochondrial hexokinase activity, but the use of another compound 
would present the same challenges in the final analysis as clotrimazole. I believe the most 
logical continuation of this project would be to systematically identify the specific 
apoptotic pathways responsible for cell death in batch culture. This would involve 
measurement of proteins at the late stages of culture, both before and after cell death, to 
identify their presence and/or activity. Since there are three major apoptotic pathways, 
then the logical choice would be to choose three markers specific to each pathway. These 
would be caspase-8 (receptor-mediated), cytochrome-c (mitochondrial-mediated), and 
caspase-12 (stress-induced).2  
 
Implications for the Biotechnology Industry 
 The underlying industrial application of this specific research project can be most 
accurately characterized as bioprocess optimization. By identifying specific molecular 
phenomena that occur or do not occur in batch culture which may contribute to cell death, 
novel opportunities for targets in optimizing cell lines to live longer and produce the 
 115
maximum amount of product are presented. Here, the intracellular movement of 
hexokinase during batch culture was investigated as a possible occurrence that could 
contribute to decreasing metabolism and eventual apoptotic cell death. Although the 
results seemingly disproved the hypothesis in many ways, the results do suggest that 
increasing mitochondrial hexokinase binding may actually be a viable option for delaying 
cell death. Specifically, are all the VDAC sites occupied? We don’t know for sure—this 
study did not include VDAC protein measurements. Again, the activity of hexokinase in 
the mitochondrial fraction did decrease, although non-statistically. This could potentially 
suggest that certain sub-populations of cells in culture do possess a deficiency in 
mitochondrial hexokinase and are consequently susceptible to the Bax-dependent 
apoptotic pathway. Here, we have some evidence that this pathway is indeed active in 
this cell line. Cell lines could potentially be made less susceptible to death by ensuring 
coverage of all VDAC sites by hexokinase, which would reduce death attributed to the 
Bax-dependent pathway in certain subpopulations. Based on obvious inoculum 
variability, the most optimal methodology for delaying cell death will almost certainly 
involve a combination of molecular targets (both metabolic and apoptotic) based on the 
pathways identified to be most active.       
 
Concluding Remarks 
 There is an increasing research to suggest that metabolic pathways do regulate 
cell survival,18 and the fact that we see declining metabolism prior to death is certainly 
strong evidence to believe that metabolism may play some role in the decision for the cell 
to die. But given the fact that there seems to be no changes in mitochondrial hexokinase 
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activity throughout batch cultures, how does this change how we think about the 
interaction between apoptotic and metabolic pathways and their regulatory functions? 
The results of this research project offer a small piece of the puzzle concerning the 
specific molecular events that occur prior to cell death in batch hybridoma cultures. The 
fact that we do not see changes in the fraction of hexokinase bound to the mitochondria in 
spinner flask cultures despite imminent apoptotic death is an interesting result. This helps 
to further limit the possibilities of how mammalian cells, particularly hybridoma cells, die 
in batch culture. The T-flasks and spinner flask appear to exhibit different physiology 
concerning metabolism and fraction of hexokinase bound to the mitochondria, suggesting 
that perhaps the mechanisms of cell death can be variable depending on culture 
conditions and even within the same culture. Does mitochondrial hexokinase matter for 
cell survival in batch culture? And does it have effects on the rate of glycolysis? Overall, 
the results of this project suggest that mitochondrial hexokinase is not critical. Re-
localization of hexokinase to the cytosol without interruption of calcium transport may 
still have an effect on metabolic and apoptotic pathways, but at present, there’s no clear 
way to determine this in vitro. At any rate, there’s no evidence that this is occurring 
naturally in batch cultures. Given these results, what is the most appropriate target to 
determine the cause of decreasing metabolism and the method of cell death? The most 
logical approach to further dissect this problem is to choose key proteins in each of the 
major apoptotic pathways and measure them at the end of batch culture, and in particular 
investigate the ER stress-mediated pathway. This would certainly elucidate the major 
apoptotic pathway(s) responsible for the natural occurrence of apoptosis in batch 
hybridoma cultures. Then, we can look for the relationship that this specific apoptotic 
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pathway (or pathways) may have with cellular metabolism to determine whether or not 
declining metabolism may signal eventual apoptotic death. Furthermore, this research 
focused on events that occur prior to the onset of apoptotic death in batch culture. 
However, the significance of changing physiological behavior during high-viability 
culture to eventual commitment to apoptotic cell death later in culture is still debatable.  
Does the physiological behavior of the cells early in the batch have any sort of influence 
over the outcome of apoptotic cell death? Before these questions can be answered, we 
must uncover the fundamental mechanisms by which the die in batch culture.            
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APPENDIX A 
 
GLOSSARY OF TERMS 
 
 
TERM DEFINITION1 
Akt/PBK 
 
Protein Kinase B; a protein which is the downstream target of PI-
3 Kinase; involved in cell survival. 
 
ANOVA 
 
Analysis of variance; a statistical method which determines if 
any pairs of means in a data set are significantly different. 
 
AO/EB 
 
Acridine orange/ethidium bromide; a florescent dye which 
differentiates among viable, early apoptotic, late apoptotic, and 
necrotic cell types based on the color and appearance of 
fragmented DNA. 
 
apoptosis A genetically determined process of cell self-destruction that is 
marked by the fragmentation of nuclear DNA, is activated either 
by the presence of a stimulus or by the removal of a stimulus or 
suppressing agent, is a normal physiological process eliminating 
DNA-damaged, superfluous, or unwanted cells (as immune cells 
targeted against the self in the development of self-tolerance or 
larval cells in amphibians undergoing metamorphosis), and when 
halted (as by genetic mutation) may result in uncontrolled cell 
growth and tumor formation; also called programmed cell death. 
 
ATP 
 
Adenosine triphosphate; contains high-energy phosphate bonds 
and is used to transport energy to cells for biochemical 
processes, including muscle contraction and enzymatic 
metabolism, through its hydrolysis to ADP.  
 
Bax A pro-apoptotic protein that binds to the mitochondria and 
facilitates the release of apoptotic proteins from the 
mitochondria. 
 
biopharmaceutical A drug created through bioengineering or biotechnological 
processes; example: recombinant protein drugs, recombinant 
vaccines, and monoclonal antibodies. 
 
clotrimazole 
 
C22H17ClN2; a specific inhibitor of Ca2+-activate K+ channels. 
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CRL 1606 
 
The American Type Culture Collection (ATCC) number for the 
hybridoma cell line used in this study. 
 
culture 
 
The growing of microorganisms, tissue cells, or other living 
matter in a specially prepared nutrient medium. 
 
cytochrome-c 
 
A 13 kDa protein involved in mitochondrial-mediated apoptosis. 
Once released from the mitochondria, it binds with caspase-9 
and Apaf-1 to form the apoptosome, which activates other 
downstream proteins. 
 
cytosol 
 
The aqueous part of the cytoplasm within which various particles 
and organelles are suspended inside a cell. 
 
DNA 
 
Deoxyribonucleic acid; a nucleic acid that consists of two long 
chains of nucleotides twisted together into a double helix and 
joined by hydrogen bonds between complementary bases 
adenine and thymine or cytosine and guanine; it carries the cell's 
genetic information and hereditary characteristics via its 
nucleotides and their sequence and is capable of self-replication 
and RNA synthesis. 
 
Dunnet’s Test 
 
A follow-up statistical test for ANOVA which compares all 
experimental means to the control. 
 
enzymatic assay 
 
A quantitative test, usually used to determine the concentration 
of a protein or metabolite, which utilizes enzymes.  
 
glucose A six-carbon sugar; the major carbon source for mammalian cell 
cultures. 
 
glycolysis The metabolic process by which glucose is converted to pyruvate 
and lactate; consists of a series of eleven enzymatic reactions.  
 
hemocytometer An instrument used to count the number of cells in a specific 
volume; a special type of microscope slide. 
 
hexokinase An enzyme catalyzing the first step of glycolysis; transfers a 
phosphate group from ATP to glucose to form glucose-6-
phosphate. 
 
hybridoma 
 
A cell that is produced in the laboratory from the fusion of an 
antibody-producing lymphocyte and a nonantibody-producing 
cancer cell, usually a myeloma or lymphoma. It proliferates and 
produces a continuous supply of a specific monoclonal antibody. 
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IMDM 
 
Iscove’s Modified Dulbecco’s Medium; a specific formulation of 
growth medium used for varying cell types. 
 
in vitro 
 
In an artificial environment outside a living organism. 
inoculum The culture used in an inoculation, or seeding, of another culture. 
 
medium 
 
A term describing the extracellular environment of a cell culture. 
metabolite Any of a number of compounds that serve as substrates for 
metabolic processes; example: glucose and lactate. 
 
mitochondria An organelle in the cytoplasm of nearly all eukaryotic cells, 
containing genetic material and many enzymes important for cell 
metabolism, including those responsible for the conversion of 
food to usable energy. 
 
monoclonal antibody Any of the highly specific antibodies produced in large quantity 
by the clones of a single hybrid cell formed in the laboratory by 
the fusion of a B cell with a tumor cell 
 
NAD+ 
 
C21H27N7O14P2; nicotinamide adenine dinucleotide; an electron 
acceptor used in various metabolic reactions. 
 
NADP+ 
 
C21H28N7O17P3; nicotinamide adenine dinucleotide phosphate; an 
electron acceptor used in various metabolic reactions. 
 
passage The process of maintaining a group of cells by regular feeding of 
fresh medium. 
 
physiology 
 
All the functions of any living organism and its parts. 
RPMI 
 
A specific formulation of growth medium used for varying cell 
types. 
 
seed 
 
To inoculate a culture such that it will grow.  
spinner flask 
 
A glass bottle containing a magnetic impeller; used for culturing 
mammalian and other cell types. 
  
supernatant 
 
The fluid above a precipitate, esp. in centrifugation. 
T-flask 
 
A plastic bottle used for mammalian cell and tissue culture. 
trypan blue 
 
A blue biological dye which permeates the cell membrane of 
dead cells. 
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Tukey’s test A statistical method that compares all pairs of means in a data 
set; usually a follow-up test for a significant model I ANOVA. 
 
UV/vis spectrometry 
 
A method of measurement performed by quantification of light 
refraction by passing wavelengths of light in the UV/visible 
spectrum through a sample. 
 
VDAC Voltage dependent anion channel; a 60 kDa protein located on 
the outer mitochondrial membrane; responsible for the release of 
apoptotic proteins into the cytosol.  
 
well plate 
 
A plastic plate containing small wells in which mammalian cells 
or tissues can be cultivated. 
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